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ABSTRACT 
Bovine herpesvirus-1 (BHV-1) is a member of the alphaherpesvirinae. 
Productive infections of the alphaherpesvirinae have short infectious cycles that 
progress through three stages of viral transcription and translation. The first 
stage, immediate-early (IE), does not require prior viral gene expression and is re­
quired for the second, delayed-early (DE), and third, late (L), stages of the 
infectious cycle. Like other herpesviruses, BHV-1 frequently establishes latent 
infections. The L stage of BHV-1 infections has been well characterized at the 
molecular level. The DE stage has been less thoroughly investigated, while the 
IE stage has remained poorly characterized. The molecular biology of establish­
ment of and reexpression from the latent state is also poorly characterized.This 
study was undertaken to better characterize the IE stage of the productive BHV-1 
infection. The number and location of IE genes and the size of IE polypeptides 
and IE mKNAs were investigated. 
Probing genomic Southern blots of BHV-1 cloned in pBK322 with ^^P-in 
vivo labeled cytoplasmic lE-RNA reveals six regions of hybridization located in 
Hindin clones D (two regions of 5.9 and 3.2 kilobase pairs [kb]), J (two regions of 
2.7 and 1.5 kb), and K (two regions of 3.0 and 1.35 kb). These results suggest as 
many as six IE genes. Sodium dodecylsulphate-polyacrylamide gel electro­
phoresis of 35S-methionine (met)-in vivo labeled BHV-1 polypeptides reveals at 
least three IE polypeptides of 180,140, and 46 kilodaltons (kD). While 3%-
methionine (met) labeled in vitro translation of poly A+ lE-KNA reveals four 
polypeptides of 180,150,140, and 46 kD. 
35s-met labeled hybrid arrested-in vitro translation of poly A+ lE-RNA 
shows that two subclones of D (pHDP6.5 and pHDP4.3) encode the three polypep-
tides of 180,140, and possibly, 46 kD. The polypeptide profile of hybrid arrested-
in vitro translated poly A+IE-RNÂ using clones J and K to block translation were 
identical to unhybridized lE-RNA controls. Northern analysis of lE-RNA using 
pHDP4.3 as probe reveals only one transcript of 5.2 kb. These data suggest the 180 
kD product is processed to the 140 and possibly the 46 kD products or that two or 
three polypeptides may be translated from the same mRNA. Thus, BHV-1 
(Cooper) contains at least one IE gene located within HindlH fragment D. This 
gene is transcribed to an mRNA of 5.2 kb The 5.2 kb mRNA encodes two poly­
peptides of 180 and 140 kD, and possibly, a third of 46 kD. It was not determined 
if the 180 kD polypeptide is processed to yield the 140 and 46 kD polypeptides or if 
the 5.2 kb mRNA contains multiple sites for initiation of translation. 
One in vitro translation ecperiment of poly A+ lE-RNA labeled with 
leucine (leu) revealed seven polypeptides of 180,150,140,46,39,37, and 35 kD. 
This suggests that several IE polypeptides may not contain methionine. The 
relationship among the other Ave possible IE genes and the leu-containing 
polypeptides of 150,39,37, and 35 kD was not investigated. 
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INTRODUCTION 
General Description 
Bovine herpesvirus-1 (BHV-1), commonly known as infectious bovine 
rhinotraecheitis (IBR) and infectious pustular vulvovaginitis-infectious pustular 
balanoposthitis (IFV-IPB or just IPV), primarily infects cattle causing respiratory 
disease, conjuctivitis, venereal disease, abortion, encephalitis, enteritis, and gen­
eralized disease in newborn, and secondarily infects most Artiodactylae (71). 
BHV-1 is one of the most significant causes of economic loss in the cattle indus­
try (274). More than 100 strains of BHV-1 have been isolated and, based on re­
striction endonuclease, polypeptide, and monoclonal antibody reactivity pat­
terns, these can be grouped into three types, two which have two subtypes: BHV-
1.1 (IBR-like), BHV-1.2a/b (IPV-like), and BHV-1.3a/b (a recent isolate with 
neuropathogenic potential) (23,27,60,61,65,78,137,148,149,152,179). IBR and 
IPV isolates are at least 95% homologous, as estimated by shared restriction en­
donuclease pattern differences (137) and filter and liquid hybridization studies 
(216). BHV-1.3 is approximately 85% homologous to IBR-IPV (61). It was once 
thought that specific strains of BHV-1 caused specific syndromes, i.e., conjunc­
tivitis was caused by a conjunctivitis-specific strain, abortion was caused by an 
abortion-specific strain, etc. However, the range of disease caused by the virus 
does not appear to be a function of a specific isolate displaying a specific organ 
tropism (except for BHV-1.3) (60,61) but is more likely caused by the route of 
infection (152). 
Historically, the disease in the United States was first noticed in a Colorado 
feedlot in 1950 (140,151). It quickly emerged as a major economic problem for 
the cattle industry in Colorado and California (143,212), and was named infec­
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tious bovine rhinotraecheitis (IBR) (144). The virus was probably introduced 
into the United States from cattle imported from Europe (142), based on reports 
of genital infections referred to as "vesicular vaginitis" and "vesicular venereal 
disease" (70,104,191). McKercher believes it is quite possible that these diseases 
were actually Blaschenausschlag (142) or IPV (109a); a genital disease of cattle re­
ported in Central Europe since the mid 19th century (71). Immunological tests 
demonstrated the identity of IBR and IPV-IPB (73,145,257) and IPV and Blasch­
enausschlag (71,141). "... serum obtained from a calf in 1941 in New Jersey was 
found subsequently to contain neutralizing antibodies to BHV-1, while seropos­
itive cattle were detected in New York state in the absence of respiratory disease 
(72)" (142). BHV-1 was probably introduced into this country as IPV and became 
associated with respiratory disease as the cattle industry began to use confine­
ment to increase yields. IBR was reported in Canada in the 1950s (79), the United 
Kingdom in the 1960s (45), at an artificial insemination center in Denmark in 
1969 (22), in Germany in 1976 (274), and today has a worldwide geographical 
distribution (273). 
The IBR virus was isolated by Madin gt al. (132a) and shown to be a herpes­
virus by Armstrong et al. (4). The family Herpesviridae can be divided into three 
subfamilies (based on host range, duration of reproductive cycle, cytopathology, 
and site of latent infection): Alphaherpesvirinae, Betaherpesvirinae and Gam-
maherpesvirinae. Herpesviridae can also be characterized by the arrangement of 
repeated sequences into goups: A, B, C, D, and E (204,207). BHV-1 is classified as 
a member of the Alphaherpesvirinae, genus Varicellovirus (28) and Group D. 
The genome of BHV-1 contains linear double-stranded deoxyribonucleic acid 
(DNA) with a first reported molecular weight of 54 megadaltons (Md) calculated 
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ft'om sedimentation velocity, a base composition of 71% G + Q and a density of 
1.730 g/ml in CsCl (210). Other researchers have reported % G + C of 71 (126), 
71.4-71.5 (75), and 72 (23,184), and buoyant densities of 1.730-1.732 g/ml in CsCl 
(75,184). The nucleocapsid has a buoyant density of 1.08-1.09 g/ml in silica-
polyethylene glycol (181). The molecular weight mentioned above is a very low 
estimate; other researchers, using restriction endonudease digests of genomic 
DNA separated on agarose gels, have measured the molecular weight (Md) of 
IBR as 84.5 (137,216) and 98.7 (60) and of IPV as 87.9 (216) and 102.8 (60). Engels et 
al. estimated the average molecular weight of BHV-1.1, BHV-1.2a/b, and BHV-
1.3a/b to be 92.1 Md (61). The best measurements for the molecular weights of 
IBR and IPV are 84.5 Md (137) and 85.5-87.9 (137,216) Md, respectively. Estimates 
larger than these were based on estimating molecular weights of bands greater 
than the largest molecular weight marker (60). Differences between the 
molecular weights of IBR and IPV can be explained by variable regions in the 
BHV-1 genome: The end fragment of the unique long segment can vary from 
2.4-2.8 kilobase pairs (kb) (81) and repetitive sequences flanking the short unique 
segment of Cooper (IBIO is 0.8 kb shorter than for K-22 (IPV) (137). Differences 
among the reported molecular weights could also be explained by minor ex­
perimental differences, including, anomalous electrophoretic mobilities caused 
by salt differences between molecular weight markers and restricted fragments, 
inherent difficulty estimating molecular weights of large fragments, and/or 
slight variations between isolates in the actual molecular weights and their 
reported values. 
The BHV-1 particle (and alphaherpesviruses in general) contains a DNA 
core (25,259) surrounded by an icosahedral capsid with 2-, 3-, and 5-fold rotation-
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al symmetries of 162 capsomeres (43,47,211,259,269). The icosahedral nucleo-
capsid (DNA core + capsid) is surrounded by a unit membrane bearing surface 
projections (43,49,249,269) of viral glycoproteins (dted in 64). The nucleocapsid 
has been variously measured, using different techniques, to have a diameter of 
h'om 90-100 nanometers Ciim) (98), 95-99 nm (43), 102-114 nm (259), and 126 lun 
(25). For herpes simplex virus-1 (HSV-1), the values range from 105 nm (269) to 
125 nm (211). The mature enveloped virus (nucleocapsid + membrane = virion) 
diameter has been measured from 145-214.5 nm with the average diameter of 
approximatdy 180 nm (4,25,35,98,211,247,259,276,277). The generally accepted 
dimensions for the Herpesviridae are 100-110 nm for the nucleocapsid and 145-
200 nm for the virion (119, 204). 
BHV-1 enters the cell by binding/attaching to the outer membrane of the 
host cell, fusing its envelope with the host membrane (complete after 30 min­
utes), and releasing an unenveloped naked nucleocapsid into the cytoplasm or, 
rarely, into cytoplasmic vacuoles (276). While being transported to the nucleus, 
the capsid disintegrates in the cytoplasm or in a cytoplasmic vacuole, releasing 
the DNA core which ultimately moves into the nucleus through a nuclear pore 
(96,159,276). From 4-6 hours postinfection (hp:) capsid formation is observed in 
the nucleus and from 6-8 hpi nucleocapsids are seen dose to the nuclear mem­
brane (98, 99, 277). The nucleocapsid buds through the nudear membrane, 
acquiring its outer coat of virally modified host membrane (5,17,19,20,169,229), 
into the perinuclear dstemae. The virion passes through a modified endo­
plasmic reticulum (ER)-tubular veside to exit the cell at the cytoplasmic 
membrane (48,98,99,159,213,277). Some researchers have reported 
nucleocapsid budding from cytoplasmic vesicles into the modified ER (35,98, 
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249). The variability seen in acquiring the virion membrane could be due to 
differences in host cell and infecting strain used. 
Productive Infection 
The lytic cycle of an alphaherpesvirus, using HSV-1 as a model, is regulat­
ed sequentially and coordinately in a cascade fashion. The three stages of viral 
transcription and translation are: alpha or immediate-early (IE), beta or early or 
delayed-early (DE), and gamma or late (L) (3,37,41,92,93,105,129). The IE genes 
are transcribed by host cell ribonucleic add polymerase n (RNApol II) (41). IE 
transcription occurs without de novo viral protein synthesis (92, 93), is further 
transactivated by a virion associated polypeptide coded for by the viral genome 
(12,29,69,117,130,131,134,146,186). IE proteins are required for activation of DE 
and L genes and also the subsequent downregulation of Aie IE genes themselves 
(55,63,68,69,116,150,162,170,171,180,182,190,260a, 278). The DE class can be 
subdivided into beta-1 and beta-2 subgroups based on their time of maximal 
synthesis (92,228,263,278). The L class can be subdivided into gamma-1 and 
gamma-2, with the former being transcribed before initiation of DNA synthesis 
and the latter being transcribed after initiation of DNA synthesis (39,89,105,136, 
228). 
The molecular biology of a productive BHV-1 infection has not been as 
thoroughly investigated as for HSV-1. The productive infection is also regulated 
in a cascade fashion. One report identifies 4 IE, 14 DE, 7 L, and 15 unclassified 
polypeptides (153). The bulk of knowledge about BHV-1 molecular biology con­
cerns the DE and L classes. DE polypeptides are generally concerned with gener­
ating a pool of nucleotides and dNTPs for DNA synthesis and the enzymes re­
quired for DNA synthesis, though, virion components are also synthesized. The 
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genes for thymidine kinase (14,157, 275), DNA polymerase (174), major DNA 
binding protein (MDBP) (dted in 270), and glycoproteins gl (122,154), gin (64) and 
gIV (dted in 270) (see below) have been mapped. Late polypeptides, generally, are 
virion components. Glycoproteins gl and gIV are expressed as DE proteins and 
gin is expressed as an L protein (125,167). Mature BHV-1 virions have been 
reported to contain a number of components ranging from 18 to 36 polypeptides 
(Table 1). 
While the structural polypeptides of the nudeocapsid have been little 
studied, there has been much interest in the glycopolypeptides that modify the 
virion envelope because of their potential as subunit vaccine candidates. This 
interest has led a number of groups to develop monodonal antibodies (MCA) 
against these components. Comparing molecular weights determined by differ­
ent groups is treacherous, but a number of similarities emerge when MCA re­
sults, immunopredpitation, and Western analysis are used. Misra etal. reported 
11 glycoproteins in the virion (153), later revised to 12 (one band was later recog­
nized as a doublet) (250). van Drunen Littel-van den Hurk e£al. reported four 
major viral glycoproteins: gl (130 kilodaltons [kD]), gll (108 kD), gin (91 kD) and 
gIV (71 kD) (251). Glycoprotein gl is a family of three related products: gla is an 
undeaved and glycosylated product of 130 kD, which is deaved to gib (74 kD) and 
glc (55 kD). Glycoproteins gib and glc dimerize via disulfide bonds to yield a 130 
kD product (250). Glycoprotein gin can form a dimer of 180 kD (250). Work by 
Marshall e£al. showed that gIV could form a dimer of 150 kD (135). Thus there 
appear to be four major core glycoproteins found in the mature virion that 
under complete reducing and denaturating conditions yield six bands by sodium 
dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE): gla (130 kD), gll 
Table 1. Structural components of BHV-1 virion comparing strain of virus, host cell and method of 
purification 
reference 
Bolton stal 
1983 (26) 
Chang et al. 
1986 (34) 
Collins etal. 
1984(38) 
Marshall etal. 
1986 (135) 
Metzler g^ai 
1985 (149) 
Misraet^. 
1981 (153) 
PastoretetaL 
1985 (179) 
Scott etal. 
1988 (215) 
Sklyanskaya etal 
1977 (223) 
Trepanier et M 
1986 (248) 
host cdl 
MDBKa 
MDBK 
BEU 
MDBK 
strain 
Cooper 
Cooper 
CSU10902-8 
Cooper-1 
MDBK/BEL Los Angdes, 
K-22, +11 
others 
MDBK/GBKh P8-2 
MDBK 
EBTri 
BEKk 
GBK 
Los Angeles, 
+ 6 others 
V722 
purification 
pb sucrose 
bd K® tartrate 
2X 
b K tartrate 
2X 
p mediums 
b sucrose 
p medium 
p sucrose 
b K tartrate 
p medium 
p medium 
b K tartrate 
pPBSi 
p medium 
pPBS(2X) 
bCsQ 
b K tartrate 
pPBS 
structural 
33 
33 
20 
22 
Orenburg 1/70 bficoll 
Los Angeles, p K tartrate 
Cooper-1, + 
36 
33 
21 
20 
18 
19-21 
glycoproteins 
ndc 
11 
7 
10 
nd 
11 
10 
10 
8 
nd 

Scott et 
1988 (215) 
EBTri V722 b K tartrate 
pPBS 
20 10 
Sklyanskaya gt al. BEK^ 
1977 (223) 
Orenburg 1/70 bficoU 18 8 
Trepanier et M GBK 
1986 (248) 
Los Angdes, p K tartrate 
Cooper-1, + 
12 others 
19-21 nd 
van Drunen Littel- GBK 
van den Hurk et al. 
1986 (250) 
1984 (251) 
P8-2 p medium 
b K tartrate 
pPBS 
nd 8 
^Madin-Darby bovine kidney cells. 
^Pellet through a sucrose cushion. 
cNot determined. 
(^Banding. 
^Potassium tartrate gradient. 
^Bovine embryonic lung cells. 
gPellet Arough growth medium. 
**Georgia bovine kidney cells. 
iPhosphate buffered saline. 
iEmbryonic bovine tracheal cells. 
^Bovine embryonic kidney cells. 
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(108 kD), gm (91 kD), gib (74 kD% gIV (71 kD) and glc (55 kD). Counting the 
different dimers that can also form and assuming that gl can also form a dimer of 
260 kD, nine of the 12 glycoproteins reported by van Drtmen Littel-van den Hurk 
and Babiuk (250) can be accounted for. 
Since the nucleocapsid is enveloped by host membranes modified by viral 
glycoproteins, it is possible that the virion contains host glycoproteins also. 
Many groups report virion components less than 50 kD and one or two of these 
are glycosylated (34,135,153,179,215,223,248). Trepanier gj al. showed that a 45 
kD host polypeptide is associated with purified virions (248). This band was very 
wide and might be a doublet (248). Othér investigators report two glycoproteins 
of approximately this size (34,153,223). Marshall g^al. reported glycosylated 
polypeptides of 45 kD and 64 kD that are components of the virion but are not 
precipitated by MCAs or convalescent serum, suggesting both originated from 
the host cell. Additionally, the 64 kD polypeptide has been shown to be 
associated with uninfected cells (135). Presuming the 45 kD proteins of Marshall 
et al. and Trepanier al. are the same, there appear to be at least two and 
probably three host glycoproteins incorporated into the virion. 
Strong parallels exist between BHV-1 and HSV-1. From 15 to 33 structural 
polypeptides of HSV-1 have been reported (201,211,228). At least seven of these 
are glycosylated and associated with the virion envelope and infected cell mem­
branes (227). Three are required for virion infectivity: gB, gD, and gH (102). The 
remaining four (gC, gE, gG, and gl) appear to be dispensible for viral replication 
in cell culture (102, 124). The three major BHV-1 envelope glycoproteins are gl, 
gm, and gTV (251). These are important for virus attachment and entry into the 
host cell (95,172,173). The three BHV-1 glycoproteins are homologous to HSV-1 
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glycoproteins gB (122,154,267), gC (64), and gD (dted in 95 and 270), respectively. 
Regions of the BHV-1 genome are homologous to the HSV-1 genes for gE, gl, 
gG,and gH also (dted in 270), but .the corresponding glycoproteins have not been 
identified. 
The variable number of structural polypeptides reported, 18 to 36 (Table 1), 
is difficult to explain. The most obvious explanation for the differences among 
these groups concerns the problems of comparing gels: quality, age, and supplier 
of reagents; quality of molecular weight markers; method of data analysis; quality 
of purified virion; anomolous electrophoretic mobility from salt effects; and deg­
radation of samples loaded onto gels. Glycoprotein patterns vary among BHV-1 
strains and host cells used to grow the virus (148,149,179). Strains of virus pas­
saged for an extended time show different glycoprotein patterns when compared 
to the same strain passaged a limited number of times in culture (86). From 
work with HSV-1, there are seven capsid polypeptides and from one to three 
tegument (a fibrous coat located between the nudeocapsid and the envelope) 
proteins in this virion (201, 211, 228). Assuming BHV-1 is similar, the virion, 
hypothetically, is composed of 17 polypeptides: seven capsid, one tegument (135), 
three host cell (135,250), and six glycoproteins (135,250). This leaves from one to 
20 polypeptides of unknown location. One major problem is the purity of the 
virion preparation. Virions prepared by banding in potassium tartrate or sucrose 
are contaminated by host membranes while banding in dextran sulfate or ficoll 
produces a much deaner preparation (206). Of the six groups reporting a low 
number of structural components, three pelleted the virus through potassium 
tartrate or sucrose (135,215,248) and one banded virions on a ficoll gradient (223). 
Of the four groups reporting a large number of structural polypeptides, three 
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banded virions on potassium tartrate gradients (26,34,153) and one repeatedly 
pelleted extracellular virus (149). Most of the groups using methods to give 
clean' preparations reported a lower number of virion components, 18 to 21 
polypeptides, while most of the groups using less clean' methods reported a 
higher number of virion components, ranging from 33 to 36 poylpeptides. Be­
cause the virus buds through modified host membranes, and Marshall g&al. re­
ported host cell glycoproteins in the virion (135), the virion may contain some 
host polypeptides that are normal components of the host membrane and which 
differ by cell type. 
. BHV-1 DNA synthesis in the cell nucleus occurs A-om 4-6 hpi until about 
20 hpi (217). The linear DNA circularizes, by an unknown mechanism (82). 
There are at least 10 DNA synthetic enzymes which have been identified for 
HSV-1 (138,273), but only three have thus far been identified for BHV-1. These 
are: thymidine kinase (110,157,264,275), DNA polymerase (174), and MDBP 
(cited in 270). There are three origins of DNA replication in HSV-1 (226,239, 
253). One is located in the long unique sequence, one is in the internal repeat 
flanking the short unique sequence, and one is in the terminal repeat flanking 
the short unique sequence. The origins of replication for two other Varicellovi-
ruses. equine herpesvirus-1 and suid herpesvirus-1, are contained in the invert­
ed repeats flanking the short unique segment (13, 21). The origins of replication 
for BHV-1 are uncharacterized. 
After circularization, HSV-1 replicates by a rolling circle mechanism, 
forming linear, head-to-tail concatemers (15,16, 20,97, 251). HSV-1 has four 
equimolar isomers that arise from one parental viral genome (Figure 1) (202, 203, 
221). Isomerization of the genome is believed to occur within or between 
Figure 1: The organization and isomerization of HSV-1 and BHV-1 (Cooper) 
genomes. (A) Four isomeric arrangements of the HSV-1 genome. 
Sequence ab and its complement a'b' (open rectangles) represent the 
repeated sequences that flank the long unique segment (long 
arrow). Sequence ac and its complement a'c' (open rectangles) 
represent the repeated sequences that flank the short unique 
segment (short arrow). (B) Size comparison of the long and short 
unique segments and die repeated sequences that flank tiie short 
unique segment of HSV-1 (top) and BHV-1 (bottom) genomes. 
HSV-1 DNA is 152.5 kilobase pairs long (139) and BHV-1 (Cooper) is 
136.9 kilobase pairs long (137). (C) Two i^meric arrangements of 
BHV-1 (Cooper) genome. The long unique segment (long arrow) 
remains fixed, only the short segment inverts, complementary . 
sequences xyz and x'y'z' (open rectangles) flank the short unique 
se^ent (short arrow) 
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Prototype; 
Inversion of long segment: 
a' b' b a a' c' c a 
Inversion of short segment; 
c'a' 
Inversion of long and short segments: 
a* b' C3 
B 
9.2 107.9 • 
103.4 
b a a c c a 
9.2 6.61-13.0-16.6 
4 11.4 H0.7H 11.4 I 
z' y' x' 
45-4 
2 V X 
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parental genomes before replication or among head-to-tail concatemers after 
replication (16, 20, 203). Recombination, intramolecularly or intermolecularly 
among genomes, occurs within the reiterated a sequence of the terminal repeat 
(36,158,224). Encapsidation is believed to occur with cleavage of the unit length 
genomes within the terminally reiterated a sequence (52,53,120,121a, 252). En­
capsidation of progeny DNA occurs approximately 2 hours after DNA synthesis 
(113) and requires one or two viral polypeptides (44,187). 
BHV-1 is presumed to replicate in a similar fashion, but there are only two 
equimolar orientations of the genome, with the short unique sequence occurring 
in both orientations relative to the long unique sequence (Figure 1). The junc­
tions between the unique long and the inverted repeat flanking the short unique 
sequence as well as the fused termini of replicative/concatemeric BHV-1 DNA 
have been cloned and sequenced, revealing a potential cleavage site within the 
fused termini of replicative DNA which is absent from the interior of the ge­
nome (82). The when and how of BHV-1 short region inversion is not known. 
Cleavage and encapsidation of progeny DNA is believed to occur by a similar 
mechanism as in HSV-1. There is homology between a sequence at the left end 
of the unique long sequence and the pac-2 site of HSV-1 which is believed to be 
involved in cleavage and encapsidation of HSV-1 DNA (82, 53). 
Latency 
Alphaherpesvirus latency is defined as a persistent infection where the vi­
ral genome remains quiescent in the body after a primary infection, cannot be de­
tected by conventional virus isolation procedures (107,240, 273), and does not 
initiate overt disease (57). The generally accepted model for the establishment of 
latency is as follows. The virus multiplies intensively during the primary in-
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faction at some local site and gains access to peripheral sensory neurons (177, 
205), though replication is not essential (234, 268). The virus then ascends the 
nerve via retrograde axoplasmic transport and enters the nucleus of the neuron 
(128). Latency can be established as early as 12 to 48 hpi either with or without an 
acute infection of the ganglion (234). Reexpression of the latent genome results 
in the virus descending the neuron via axoplasmic transport and the infection of 
cells at or near the original site of entry (205,209). After initial BHV-1 infection 
(naturally, experimentally, or vacdnally) and humoral and cellular immune re­
sponses (107,220), the virus can be recovered intermittently for at least 578 days 
(225a). Latent BHV-1 can be reactivated by a variety of stimuli including trans­
port (244), parturition (225a, 245), intraruminally administered 3-methylindole 
(62), Dictvocaulus viviparous infestation (160), superinfection with parainflu-
enza-3 (245), and administration of glucocorticoids (46,50,106,178,208,219). 
Between episodes of viral expression the animal appears clinically normal 
(177). During episodes of viral shedding clinical symptoms vary from asympto­
matic (22,94,118,175,225a) to mild (30) to as severe as the primary infection (50). 
The reexcreted virus shed from latently infected animals has similar properties 
to the strain of primary infection. These properties include growth characteris­
tics (176,199), restriction endonuclease digestion patterns (31,176,243) and infec-
tivity (30,199). Changes in restriction patterns can however occur during both 
acute infection in vivo and in virus reactivated A"om latency (31, 266). 
Vaccination, generally, does not protect against the establishment of laten­
cy and subsequent reexpression of BHV-1 (168,177). Attenuated vaccine strains 
also establish latent infections (176,177). Two strains can remain latent in the 
same host when the initial infections occur months apart (265). Both vaccine 
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and field strains can cause latent infections and be reexpressed in the same ani­
mal (168). It is not known if recombination occurs between two latent strains or 
between superinfecting and latent strains (168,246), but recombination between 
two strains of suid herpesvirus 1 (Pseudorabies), another Varicellovirus. occurs 
during coinfection of the same animal (108a). Also, two a virulent strains of 
HSV-1 coinoculated onto the footpads of mice can recombine in vivo producing 
viru-lence (100). So, the potential for recombination between strains clearly 
exists. A subunit vaccine based on three BHV-1 glycoproteins, gl, gm, gIV, 
protects cattle from clinical disease, but not from infection. It was not 
determined in this study if this protection prevented establishment of latency of 
the challenge virus (6). Antibody titers to BHV-1 do protect against clinical 
disease, but latency may be established, and reexpressed virus recovered later (22, 
94,112,118,177). 
Calves intranasally (163) and intraconjunctivally (164) inoculated with 
BHV-1 display ganglionitis, suggesting the trigeminal nerve can be a site of infec­
tion. Administration of dexamethasone to latently infected animals shows gan­
glia to be the first tissue affected/infected during reexpression (166). This suggests 
that the neuron is a site of latency (165,195). Supporting this is the observation 
that BHV-1 has been isolated from trigeminal ganglia by cocultivation with sus­
ceptible cells of explanted ganglia from a dairy herd where 45% of die animals 
tested BHV-1 antibody positive (90). BHV-1 DNA has also been detected by in 
situ hybridization, in trigeminal ganglion nuclei during latency following both 
tracheal (2) and intranasal (91) inoculation. BHV-1 DNA, detected by in situ 
hybridization, is also present in sacral ganglia neuron nuclei during latency after 
intravaginal inoculation (1). 
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Latent BHV-1 is transcriptionally active in rabbit trigeminal ganglia, with 
RNA primarily accumulating in the nucleus (197). The region of BHV-1 (Coop­
er) genome transcriptionally active during latency maps to a 1.9 kilobase pair (kb) 
region of Hindm fragment D (map units 0.734 to 0.842) and is transcribed from 
left to right (196). It is presumed that this latency associated transcript (LAT) is 
also synthesized during latency in bovine trigeminal ganglia, but this experiment 
has not been done. DNA sequence analysis reveals two major open reading 
frames (ORF) with the approximate map positions of the LAT and a potential 
RNApol n promoter near the 5' terminus (Jones gtal., unpublished data, cited in 
103). This promoter can be transactivated by BHV-1 infection in bovine cells and 
is efficiently transcribed late in a lytic infection (103) and can be detected at the IE 
stage of infection (270). Antibodies raised against a synthetic peptide predicted by 
ORF 2 of the LAT identified a protein doublet of 33-35 kD at 6 hpi and in purified 
virions, but not in uninfected confrols (86). It is not known if the LAT is trans- . 
lated in neurons. Dexamethasone decreases levels of LAT in latently infected 
ganglia (103). Work with HSV-1 implicates decreased levels of LAT with an early 
stage in reactivation from latency (231). One can speculate that dexamethasone 
treatment of latently infected animals causes reactivation by decreasing synthesis 
of LAT. The function of this LAT is presently unknown. 
Similar work has been conducted with herpes simplex virus. Inoculation 
with HSV-1 also results in a latent infection of the local sensory ganglia (8, 258). 
HSV-1 has been isolated from latently infected spinal ganglia of mice after ex-
plantation and organ cultivation (10, 111, 237) and from latently infected rabbit 
spinal ganglia (185). HSV-1 has been isolated from human trigeminal ganglia at 
autopsy after explantation and cocultivation from individuals without signs of 
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active disease (9,11,183). It is clear that the neuron is the primary site of latency 
(40, 236,242) and that the virus arrives at the site of latency via retrograde 
axoplasmic transport (128). 
A number of animal, models have been used to study herpes simplex vi­
rus latency. These include: mice, rats, guinea pigs, and rabbits inoculated peri­
pherally (eye, ear, footpad, vagina), intracerebrally, or systemically (peritoneum 
or circulatory system) (205). The most commonly used model is the mouse inoc­
ulated at the eye or footpad. Spontaneous reactivation in this system is low and 
experimental reactivation of latency cannot be studied (7, 205). Another mouse 
model using inoculation of the ear shows a low rate of spontaneous reactivation 
(3.5%) and a reactivation rate induced by ultraviolet light or trauma (cellophane 
stripping of the ear) of 30-50% (24,88). Generally, latently infected mice show a 
low incidence of reactivation. In humans, there are a variety of stimuli which 
cause reactivation Arom latency. These include the following: trigeminal nerve 
rhizotomy or tractotomy, pesticides, trauma, anaphylactic shock, Arthus reaction, 
adrenalin, pituitary hormones, menstruation, streptococcal infection; excessive 
exposure to cold, wind, or sunlight; ultraviolet light, immimosuppressive 
therapy or immunosuppressive disorders (57); emotional stress (200); and 
leukemia, malnutrition, and fever (235). Also implicated as possible stimuli of 
herpes simplex virus reactivation from latency are multiple sclerosis, nasopha­
ryngeal carcinoma. Cannabis spp. (57) and malaria and pneumococcal 
pneumonia (200). 
Like BHV-1, the herpes simplex virus genome is transcriptionally active 
in latently infected neurons (66,67,189,241, 242). The genomic region that is 
active has been mapped to the ICPO gene (51,188,198,230,238). Latently HSV-1 
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infected murine spinal ganglia expresses a 2.6 kb RNA complementary to the 
coding strand of ICFO (238). HSV-1 latently infected trigeminal ganglia of rabbits 
show two products, a major RNA of 1.8-2.2 kb complementary to the 3' end of 
the ICPO gene and a minor RNA complementary to the 5' end of the ICPO gene 
(198). HSV-1 latently infected trigeminal ganglia of mice show three transcripts of 
2.0,1.5, and 1.45 kb all partially oolinear on the genome and partially overlapping 
the 3' end of ICPO but transcribed in the opposite direction (230). While the exact 
sizes of the LAT varies in these reports, the LATs are located in a similar place on 
the genome and are all complementary to the coding sequence for ICFO. The 3' 
ends of LAT and ICPO overlap by approximately 1 kb (262). 
The LAT of HSV-1 and its gene have been further characterized. The gene 
has been sequenced for three HSV-1 strains revealing a promoter region contain­
ing CÀAT and TATA sequences and Spl binding sites at -700 to -800 (261). Dele­
tion of this promoter abolishes synthesis of LAT in neurons (56,156). Most LATs 
are not polyadenylated (255,256). The closest polyadenylation site is 8.3 to 8.5 kb 
from the promoter region (56,155). In situ hybridization of HSV-1 latently infec­
ted ganglia reveals faint regions of hybridization between the LAT promoter and 
5' cap site and from the 3' end to the polyadenylation site, suggesting that the 
LAT is synthesized as a primary transcript of 8.3 to 8.5 kb that is differentially 
spliced to yield a major LAT of 2.0 kb and minor LATs of 1.3 to 1.5 kb (56,155, 
156). The major LAT contains a small intron at the 5' end (253). The minor 
LATs have a second intron of approximately 0.7 kb removed near the 3' end (255, 
256,261,262). 
The function of the LAT is not known, though it may function in reac­
tivation Arom latency. Deletion mutants of HSV-1 lacking the gene for LAT can 
1 9  
establish and maintain latency comparable to wild type virus (101,218), but reac­
tivates at a reduced frequency (87,123). Decreased levels of LAT are associated 
with reactivation of latent HSV-1 from explanted ganglia (231). The LAT would 
code for a polypeptide that is positively charged, but antibodies raised to synthetic 
oligopeptides that could be coded for by the LAT revealed no peptide when used 
to probe latently infected ganglia (261). 
The state of the latent genome in model systems agrees with what has 
been reported for HSV-1 latently infected humans, k situ hybridization of au-
topsied human trigeminal ganglia revealed a 2.7 kb RNA complementary to the 
ICPO gene; ICPO mRNA was not detected (42,74). Northon analysis of total 
RNA extracted from ganglia obtained at autopsy from humans who had no evi­
dence of active herpetic infection at the time of death revealed two transcripts 
complementary to the same strand of ICPO, 1.35 and 1.85 kb (115) and 1.5 and 2.0 
kb (233). The gene transcribed during latency is different from the gene tran­
scribed during productive infections (232); the LAT is barely detectable during 
lytic infection of cells in culture (7). Probes for other IE genes ([CP4, ICP22, ICP27, 
and ICP47), some DE and L genes (approximately 80% of the genome) show no 
evidence for expression during latency (51). 
Genomic HSV-1 DNA exists as four equimolar isomers. Each of these iso­
mers can establish latency. All four are found in latently infected mouse central 
and peripheral nervous systems and human trigeminal ganglia (59). In acutely 
infected mouse brainstems, the genome is linear and is predominantly nonnu-
cleosomal (161). Further investigations into the structure of the latent DNA us­
ing the mouse central nervous system shows the genome is "endless," circular­
ized or concatenated (193,194), extrachromosomal (147), nucleosomal (54), and 
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not extensively methylated (58). Latently infected human trigeminal ganglia al­
so show the "endless" state for the HSV-1 DNA (59). The structure of BHV-1 
DNA during latency has not been investigated. 
Project 
The relationship between the LAT of both BHV-1 and HSV-1 and the neu­
ron is not known. There is a large body of information on the molecular biology 
of HSV-1 productive and latent infections. While there is less known about the 
molecular biology of BHV-1, especially the IE stage of productive infection, the 
study of BHV-1 latency is worth pursuing because the latent virus can be studied 
in its natural host (Bovidae) and in a laboratory model system-the rabbit (127, 
195). The study of HSV-1 latency in its natural host must remain indirect (205). 
The best model system is the mouse where establishment and maintenance can 
easily be studied but reexpression cannot; the best reexpression system reports 30-
50% success rate (88). BHV-1 reexpression can be induced by glucocorticoids with 
a success rate close to 100% for both the natural host (133) and model system 
(195). 
The study of BHV-1 latency suffers in comparison to the study of IfôV-1 
latency because of the limited knowledge of the molecular biology of both pro­
ductive and latent infections. This work was undertaken to investigate the mo­
lecular biology of BHV-1 productively infected cells grown in culture, concen­
trating on identifying the immediate-early gene(s) and gene product(s)-polypep-
tide(s) and mRNA(s). The ultimate goal is to understand the mechanisms and 
events leading from maintenance of latency to expression of the latent genome. 
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MATERIALS AND METHODS 
Virus and Cell Culture 
Madin-Darby bovine kidney cells (MDBK) (received from National 
Veterinary Services Labs, Ames, Iowa) were maintained in Eagle minimum 
essential medium (MEM) (Gibco cat. no. 410-1500), Earle's salts, with 1.6 g/1 
NaHCOs, 0.292 g/1 L-glutamine, 2.0 g/1 HEPES, 2.0 g/1 lactalbumin hydrolysate, 
and supplemented with 10% fetal bovine serum (FBS). 
The Cooper strain of BHV-1 was passaged on confluent monolayers of 
MDBK cells infected at an multiplicity of infection (moi) of 0.01-0.1 plaque 
forming units (pfu)/cell. Supematants were collected when monolayers 
exhibited 100% cytopathic effect (48-72 hours), then cleared of cellular debris, 
aliquoted, and stored at '70°C. Ten-fold dilutions were titred on confluent 
monolayers of MDBK cells grown in 24-well plates. Each assay was done in 
duplicate. Virus was adsorbed for 11/2 hr. The inoculum was removed and 
overlayed with 0.5 ml 1% SeaKem (ME) agarose (FMC, Corp.), IX MEM, and 2% 
FBS. The cells were incubated at 37oC until plaques formed, about 48 hr. The 
cells were fixed in 1.5 ml 10% neutral buffered formalin for 1 hr at room 
temperature (RT) and stained with 1% crystal violet (in 95% ethanol) for 30 min 
at RT. The plaques were counted and the two titres were averaged. The typical 
titre was 1 x 10^ pfu/ml. 
Uninfected Controls 
All experiments included uninfected cells. These cells were handled 
exactly as infected cells except virus was not added. 
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Electrophoresis of Proteins 
Sodium dodeqrlsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
was carried out as described by Laemmli (121b), except betamercaptoethanol 
(BME) was not added to the sample buffer until just before boiling. After 
electrophoresis, gels were stained in 0.1% Coomasie brilliant blue R-250 
dissolved in 25% 2-propanol and 10% glacial acetic add (gHOAc) and destained in 
25% 2-propanol and 10% gHOAc. Molecular markers were purchased from 
Sigma (SDS-high or -low). 
Fluorography and Autoradiography 
Destained gels were soaked in 3-4 gel volumes of glacial acetic add 
(gHOAc) for 15 minutes with gentle shaking. The gHOAc was poured off and 
replaced with 20% PPO (2,5-diphenyloxazole) (wt/wt) in gHOAc, (100 ml for 15 
cm gels, 200 ml for 30 cm gels) for 1 hr with gentle shaking. The PPO was 
removed, replaced with 3-4 volumes of distilled water and shaken for 1 hr. The 
water was removed, and the gel was dried down using a Biorad gel dryer as stated 
in the instructions supplied by the manufacturer. The dried gel was exposed to 
Kodak X-ray film (XAR-5) at -ZO^C. The same Him and conditions were also used 
for Southern and Northern analyses. The Him was developed as stated in the 
instructions supplied by the manufacturer. 
Time Course of Infection 
Two X 105 MDBK cells (one well of a 24 well plate), 95% confluent, were 
infected at an moi of 10 and adsorbed for 1 hour. At 1 hpi the inoculum was 
removed and 0.5 ml MEM with 5% FBS was added. At 2 hr intervals the 
medium was removed from one well. The monolayer was washed once with 
phosphate buffered saline, pH 7.5, (PBS). The cells were labeled for 1 hr with 200 
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microliters of 100 microCi/ml ^Ss-methionine (Amersham, Corp.), 10% met-
MEM (containing 10% methionine of normal medium), and 1% FBS. After 1 hr, 
the labelling medium was removed and monolayers washed once with PBS. 
Cells were lysed in 200 mM NaCl, 2 mM EDTA, 10 mM Tris-HCl (pH 7.5), 1% 
Triton X-100,1 mM PMSF (phenylmethylsulfonyl fluoride), and 1% aprotinin. 
Monolayers were scraped with a rubber policeman, pipetted into a 
microcentrifuge tube, and stored at -70oC until all time points were collected. 
The samples were thawed and nuclei were separated from cytoplasm by 
centrifugation 4oC/5 min/10,000 x g. The cytoplasmic fraction was added to an 
equal volume of 2X sample buffer (62.5 mM Tris-HCl [pH 6.8], 2% SDS, 10 % 
glycerol, 5 % BME, and 0.001% bromophenol blue) (121b) and half used for 
electrophoresis. The nuclei were suspended in micrococcal nuclease buffer (5 
mM CaClg and 10 mM Tris-HCl, pH 8.0) and digested with 2.5 microliters (1 
mg/ml in 10 mM Tris-HCl, pH 8.0) of micrococcal nuclease (nuclease from 
Staphylococcus aureus) at 37°C for 30 min. An equal volume of 2X sample buffer 
was added and half the sample was used for electrophoresis. The gel was stained, 
destained, and fluorographed as described above. The film was exposed for 16 hr. 
IE Polypeptide Identification 
Two X 105 MDBK cells, one well from a 24-well plate, were infected at an 
moi of 100 in the presence or absence of cydoheximide (CHX) (50 micro-
grams/ml) for 1 hr. After 1 hr the inoculum was replaced with 0.5 ml MEM, 5% 
FBS, with or without CHX. After 7 hr the medium was removed and the 
monolayers were washed 4 times with 10% met-MEM and 2% FBS either with or 
without actinomycin-D (20 micrograms/ml) (Sigma). The cells were labeled in 
the presence or absence of the appropriate drug for 2 hr with 100 microCi/ml 35s-
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met 10% met-MEM, and 2% FBS. After 2 hr, the labeling medium was removed, 
the monolayers were washed once with PBS, and the cells lysed with 150 mM 
NaCl, 2 mM PMSF, 2 mM EDTA, 10 mM TYis-HCl (pH 7.5), 1.5% triton X-100,5 
mM CaClz and 2.5 microliters micrococcal nuclease (1 mg/ml) at 37°C for 30 min. 
A 1/5 volume of 5X sample buffer was added and the samples were separated on 
a 30 cm 7.5-18% gel, stained, destained, and fluorographed as described above and 
exposed to film for 24 hr. 
Superinfection 
Two X10^ MDBK cells were infected at an moi of 500 in the presence of 100 
microCi/ml 35g.met. After two hr the cells were harvested as described above 
and included on the same gel. 
BHV-1 Clones 
The Hindin fragments of BHV-1 (Cooper) used were cloned and described 
in 137, also see Figure 5. 
Plasmid DNA Isolation and Cloning 
The procedures used were as described in Maniatis gtal- (132b). The 
bacterial host was E. cgli strain HBlOl and the vector was pBR322. Restriction 
endonucleases and DNA ligase were purchased from Bethesda Research 
Laboratories. 
Southern Blotting 
The blotting procedure of Southern (225b) as described by Maniatis etal. 
(132b) was followed except the membrane used was GenaTran 45 (D & L Filter 
Corp., Woburn, MA ). Membranes were prehybridized in 60% deionized 
formamide, 5X SSC (IX SSC is 0.15 M NaCl and 0.015 M Na citrate, pH 7.0), lOX 
Denhardt's solution (IX is 0.02% each of ficoll, polyvinylpyrrolidone, and bovine 
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serum albumin [BSA]), 0.1% SE)S, 5% dextran sulphate, 500 micrograms/ml 
sonicated denatured salmon sperm DNA, and 0.2% BSA for 48 hr at éO^C with 
agitation. The hybridization solution was the same as the prehybridization 
solution. The probe was added to the prehybridization solution and 
hybridization went for 24-48 hr at 60oC. Membranes were washed twice in 2X 
SSC at RT, twice in 2X SSC at 60oC, twice in IX SSC at 60oC, and twice in O.IX SSC 
at 60OC. All washes were done with gentle agitation. After washing, the blots 
were air dried for 30-45 min and exposed to X-ray film. Exposure times varied: 
nuclear lE-RNA, 14 days; cytoplasmic lE-RNA, 10 days; other exposures varied 
from 14-21 days. 
RNA Isolation for Southern Blot 
Seventy-five cm^ flasks of MDBK cells, 50-70% confluent, were placed in 
phosphate-free MEM overnight (about 18-24 hr). One hr before infection 50 
micrograms/ml CHX was added. After 1 hr, the medium was removed and the 
cells were infected at an moi of 15-30 along with 50 micrograms/ml CHX, and 200 
microCi/ml 32pH>rthophosphoric add in HCl-free water (New England Nuclear), 
and fresh phosphate-free MEM. After 1 hr, FBS was added to 5%. After 5 1/2 hr, 
the monolayers were washed three times with PBS, once with ATV (saline A, 
trypsin, versene: 137 mM NaCl, 5.3 mM KCl, 8.3 mM NaHC03, 0.1% glucose, 
0.05% trypsin [Difco], and 0.53 mM versene [Na2EDTA]) and removed with 5 ml 
ATV, 370c for 10-15 min. The cells were iced for 5 minutes and pelleted at 2,000 x 
g for 5 min at room temperature. The supernatant was discarded, the cells 
suspended in 1 ml of ice cold 100 mM NaCl, 10 mM Tris-HCl (pH 8.6), 10 mM 
EDTA, 0.5 mg/ml heparin, and 100 microliters BME, and lysed on ice for 15-30 
seconds by addition of triton X-100 to 2%. Nuclei were pelleted at 16,000 x g for 3 
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min at 4oC. The cytoplasmic fraction was added to 2 ml distilled phenol + 0.1% 8-
hydroxyquinoline, 2 ml CHCla, 2% SDS, and 100 microliters BME. The nuclei 
were suspended in 1 ml cell lysis buffer and added to a second tube containing 2 
ml phenol, 2 ml CHClg, 2% SDS, and 100 microliters BME. Both fractions were 
extracted until the interface was clear usually 4 to 6 times. The second through 
sixth tubes used to extract the RNAs did not contain SDS. The fractions were 
extracted twice with CHCI3, without BME, and precipitated in 70% ethanol and 2 
M NH4OAC overnight at -20oC. The pellet was ethanol precipitated 6 more 
times. After the last precipitation the pellet was taken up in 1 ml 
diethylpyrocarbonate (0.1% by volume) treated water and added to the 
prehybridization solution. 
RNA Isolation for Northern Analysis and In Vitro Translation 
MDBK cells were cultured and infected as above in 150 cm^ flask, except 
normal MEM and no isotope was used. At harvest the monolayers were washed 
once with PBS and lysed in situ with 4 M guanidinium isothiocyanate and 
pelleted through CsCl as described by Kingston (109b). The RNA pellet was 
extracted with 2X volume phenol and (ZHCls, extracted once with twice the 
volume CHCI3, precipitated in 72% ethanol and 2 M NH4OAC and stored at -20oC 
until needed. 
Poly A+ RNA Selection 
Oligo dT cellulose (Collaborative Research incorporated) was suspended, 
used, reused and stored as stated in the instructions provided by the 
manufacturer. Total cellular RNA was taken up in 100 microliters of DEP-
treated water, heated at 650C for 5 min and placed on ice for a minimum of 15 
min. The RNA was centrifuged at 16,000 x g for 5 min at 4PC to remove 
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insoluble material. The supernatant was added to 500 microliters of binding 
buffer (0.5 M KCl, 10 mM Tris-HCl [pH 7.8], 1 mM EDTA) and loaded onto the 
column. Poly A+ RNA was eluted in 10 mM Tris-HCl, pH 7.8, and 1 mM EDTA. 
The RNA was placed in 2-5 microgram aliquots, precipitated in 72% ethanol and 
2 M NH4OAC, and stored at -20PC until needed. 
Northern Analysis 
Total cellular RNA was denatured with deionized glyoxal (Kodak 
Chemicals) and separated by agarose electrophoresis as described by Maniatis et 
al. (132a). Blotting and binding to, and stripping of, the membrane (Zetaprobe-
Biorad) was done according to the instructions provided by the manufacturers. 
Prehybridization was in 60% deionized formamide, 2X SSC, 5% SDS, 10% 
polyethylene glycol (molecular weight 8,000), 0.5 % soy milk, and 300 
micrograms/ml sonicated-denatured herring sperm DNA at RT for 2 hr and at 
6O0C for 1 hr. Probe was added to the prehybridization solution and hybridized at 
6O0C for 18-24 hr in a shaking incubator. The blot was washed twice in 2X SSC + 
0.1% SDS at RT, twice in 2X SSC + 1% SDS, twice in 0.5X SSC + 0.1% SDS, and 
once in O.IX SSC + 0.1% SDS. The wash buffers were heated to 65°C in a water 
bath and a shaking incubator set at SO^C was used for gentle agitation. The blot 
was wrapped in plastic wrap and exposed to X-ray film for 18-24 hr. 
Nick Translation and Gel Purified Fragment 
Nick translations were performed with alpha[32p].dCTP using a nick 
translation kit (BRL). Cloned DNA was cut with appropriate restriction 
endonucleases so the DNA of interest could be unambiguously separated from 
vector and other sequences. A 0.6% Sea Plaque agarose (FMC, Corp.) gel was 
poured and run in 50 mM Tris-acetate (pH 8.2), visualized by staining in 
2 8  
ethidium bromide (1 microgram/ml), and the band excised A-om the gel in as 
small a volume as possible. The DNA in agarose was melted at 650C and the 
volume was brought up to 35 microliters with water (provided with the nick 
translation kit) and placed at 42oC. Nick translation reagents, except DNA 
polymerase/DNase were added. The tube was placed on ice and 
polymerase/DNase added, mixed well and incubated at lé^C for 1 hr. 50 mM 
EDTA, 2 M NH4OAC, and 20 micrograms tRNA were added to the reaction mix 
and heated at ôS^C for 5-10 min to remelt the agarose. Two volumes ethanol 
were added and the DNA was precipitated overnight at -20oC. The DNA was 
ethanol precipitated twice to remove unincorporated nucleotides. The pellet was 
taken up in 300 microliters of water, boiled for 5-10 min, placed on ice for a 
minimum of 15 min and added to the northern blot prehybridization solution. 
In Vitro Translation 
In vitro translation kits (minus met and minus leu) were purchased from 
BRL. 35S-met was purchased from New England Nuclear (translation grade) and 
^H-leu was purchased from Amersham, Corp. Two to 5 micrograms of poly A+ 
RNA was used per reaction and the procedures as described in the kit 
instructions were followed. Electrophoresis, staining, destaining, and 
fluorography were conducted as stated above. 
Hybrid Arrested-In Vitro Translation 
Three to 5 micrograms of lyophilized poly A+ RNA was taken up in 10 
microliters of 10 mM Tris-HCl (pH 8.0), and 5 mM EDTA containing 10 
micrograms of linear denatured plasmid. The solution was heated at 65oC for 5 
min, placed on ice for 5 min, then 40 microliters of 80% deionized formamide, 
500 mM KG were added, and the samples were allowed to hybridize at 45oC for 4 
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hr. Each sample was ethanol precipitated overnight at -20oC. The DNA/RNA 
pellets were washed five times in 72% ethanol kept at -20oQ dried, taken up in 
water, and translated in vitro as stated above. 
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RESULTS 
Immediate-Early Polypeptides 
IE polypeptides, by definition, are the first gene products expressed during 
infection and, also, are the only gene products which do not require prior viral 
gene expression. Thus, bonafide IE polypeptides should both occur very early in 
the infectious cycle and also be encoded by viral mRNA which is produced dur­
ing a cydoheximide (CHX) block of the early stages of infection. Figure 2 shows a 
time course of a normal BHV-1 infection. Five X 10^ Madin-Darby bovine kid­
ney cells (MDBK) cells were infected with BHV-1 at an moi of 10 plaque forming 
units/ml (pfu/ml) and at 2 hr intervals the cells were labeled with ^^S-methio-
nine for 1 hr. Cytoplasmic fractions were isolated, proteins extracted, and separ­
ated by sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
on a 7.5-15% gradient gel and visualized by fluorography. Twelve to 15 new 
polypeptides are already evident at the two hour time point. These polypeptides 
are presumed to be BHV-1 specific, though some may be cellular polypeptides in­
duced upon virus infection; we have not investigated this possibility. IE poly­
peptides are synthesized prior to DE and L polypeptides and then at a decreasing 
rate during the remainder of the infectious cycle. The first time point shows 
what is being translated 2 to 3 hr into the infection, and presumably, represents a 
mix of all classes. Comparison of 6 and 8 hpi to 2 hpi reveals bands which in­
crease, bands which remain more or less the same, and bands which decrease in 
intensity. Bands of 85 kD, 140 kD, and 180 kD all decrease after two hours and are 
potential IE polypeptides. Bands of 30,35,40 and 46 kD are prominent at two 
hours but appear to peak at 6 hours. Because of the variability from experiment 
to experiment these polypeptides are also IE candidates. 
Figure 2: Fluorograph of BHV-1 (Cooper) polypeptides syntiiesized at various times during the 
infectious cycle. The polypeptides were separated by SDS-PAGE on a 75-15% gradient gd. (U), 
uninfected cells, hpi, cells labded at 2,4,6,8,10, and 12 hours post infection. Each time point 
consists of a cytoplasmic (right) and nuclear (left) lane. Arrows, potential IE polypeptides of 
170/180,140, and 85 kD. (M), molecular markers (kD) 
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It is possible that some IE polypeptides are synthesized from prior to 2 hpi. 
To identify the polypeptides synthesized during the earliest stages of the BHV-1 
infectious cycle we superinfected 5 X 10^ MDBK cells with BHV-1 at an moi of 500 
pfu/ml in the presence of 35s-methionine (50 microCi/ml), extracted total pro­
tein after 2 hr, separated them by 7.5-15% gradient SDS-PAGE and visualized by 
fluorography (Figure 3, lanes 4a and 4b). Infecting cells at a high moi hastens vi­
rus induced shut-down of host polypeptide synthesis, reducing the background 
of host polypeptides and also increasing the viral proteins synthesized, making it 
easier to detect viral polypeptides (data not shown, 180a). Comparing 4a to 4b 
shows at least three new polypeptides are synthesized upon viral infection dur­
ing the first hour of the infectious cycle: 85,140, a doublet at 180, and possibly 46 
and 150 kD. Some or all of these are IE polypeptides. 
To further identify which of these polypeptides are IE we utilized the ob­
servation that lE-RNA is transcribed in the presence of cycloheximide. If the 
cycloheximide is then washed out of the cells in the presence of actinomycin-D, 
an inhibitor of transcription, lE-mRNA is translated, but transcription and then 
translation of DE and L genes, which are induced by IE polypeptides, will be 
blocked. Following this regime, we should only detect translation of IE polypep­
tides (92,153). Five X10^ MDBK cells were infected with BHV-1 at an moi of 100 
pfu/ml in the presence or absence of CHX (50 micrograms/ml) for 7 hr. CHX was 
washed out of the cells in the presence or absence of actinomycin-D (20 micro-
gram/ml) and labeled with 35S-methionine for 2 hr. Total protein was extracted, 
separated on 7.5-15% SDS-PAGE and visualized by fluorography. The results are 
shown in Figure 6. Lane pairs 1 and 6 are CHX controls. Lanes la and lb contain 
proteins A-om cells which were treated for seven hr with CHX and then released. 
Figure 3: Fluorograph of BHV-1 polypeptides synthesized in the 
presence or absence of CHX and/or actinomydn-D (act-D) 
separated by SDS-PAGE on a 7.5-18% gradient gel. Lane pair 
1/ cells treated with CHX for 8 hr, washed without act-D, and 
labeled for 2 hr without act-D. Lane pair 2, no drug present 
for 8 hr prelabel, washing, and 2 hr labelling. Lane pair 3, 
cells treated with CHX for 8 hr, washed with act-D, and 
labelled for 2 hr in the presence of act-D. Lane pair 4, 
superinfection of cells at an moi of 500 in the presence of 
laW for 2 hr. Lane pair 5, cells without drug treatment for 
prelabel, washed in Ôie presence of act-D, and labeled for 2 hr 
in the presence of act-D. Lane pair 6, cells treated with CHX 
or 8 hr, washed without drug present, and labelled for 2 hr in 
the presence of CHX. a, uninfected controls, b, BHV-1 
infected cells at an moi of 100, except lane 4b. M, molecular 
markers (kD). Three wide solid arrows, potential IE 
polypeptides of 175/180,140, and 46 kD. Two wide outline 
arrows, viral polypeptides of a different class of 150 and 100 
kD. Other arrow, 85 kD polypeptide of unknown affiliation 
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These samples demonstrate that CHX can be efficiently washed out of the cells. 
The samples in lane pair 6 were blocked with CHX for the entire experiment 
Under the conditions used no polypeptides are visible on the gel. Lane pair 2 
represents a normal infection. Note that the pattern of peptides seen in lane 2a, 
though darker, is virtually the same as that seen in lane la. Lane pair 3 contain 
cells blocked with CHX and subsequently washed and labeled in the presence of 
actinomydn-D. Peptides seen in lane 3b should be IE viral products plus trans­
lation products of very stable cellular mRNAs. Bands of 205/180-170,150,140, 
and 46 kD can be seen in land 3b. The faint band at 205 kD is most likely the 
product of a cellular gene because a major band at this molecular weight is seen 
in all uninfected controls. The other bands are probably virus encoded polypep­
tides. The bands of 150 and 100 kD appear to be the same as major late polypep­
tides (see lanes 2b and 5b, Figure 3; and Figure 2). Thus prime candidates for IE 
gene products are polypeptides of 180-170,140, and possibly 46 kD. Lane pair 4 
were previously discussed. Lane 4b contains superinfected cells labeled for the 
first hour of infection. Lane pair 5 is another control containing cells untreated 
with CHX, but labelled in the presence of actinomydn-D. The observed band 
pattern, as expected, is very similar to the seen in lane pair 2. 
In summary, ^^methionine labeling experiments indicate that polypep­
tides of 180 and 140 kD are prime candidates for IE genes products. The case for 
the 46 kD polypeptide is less compelling, but it remains a candidate. The case for 
other polypeptides is weaker. An 85 kD protein is dearly visible in all early time 
points of infection, but is absent from the CHX block experiment (Figure 3, lane 
3b). This phenotype might be expected of a cellular protein which is produced in 
response to viral infection. 
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Immediate-Early Transcripts 
The location of immediate-early transcripts on the viral genome from 
BHV-1 (Cooper) infected MDBK cells grown in culture was determined by the 
Southern blot technique. Cytoplasmic RNA labelled with 32po4 was extracted 
from 5 1/2 hr BHV-1 infected CHX treated MDBK cells and was used to probe, 
under stringent hybridization conditions. Southern blots of genomic BHV-1 
DNA that had been cloned into pBR322. Controls were treated identically as 
infected, except no virus was added. Cells infected with BHV-1 in the presence of 
CHX accumulates lE-RNA, but cannot synthesize DE or L transcripts in the 
absence of IE polypeptides. CHX, under the conditions used, inhibited protein 
synthesis by 98%, as measured by ^Sg-methionine incorporation into TCA 
predpitable counts (data not shown). The results are shown in Figure 4 and 
Table 2 and are summarized in Figure 5. Clones D, J, K, and O show the strongest 
intensity of hybridization and potentially contain IE genes. Clones I, G, L, and A 
show faint intensities of hybridization. These clones are not thought to contain 
IE genes. It is possible that the less than 100% inhibition of translation by CHX 
may have permitted translation of some IE transcripts, triggering transcription of 
some DE or L genes or that regulation of some DE or L promoters is not perfect. 
Clones B, E, and M showed no hybridization. 
In another experiment, the same blots that were hybridized to cytoplasmic 
RNA were stripped and reprobed with nuclear RNA from virus infected CHX 
blocked cells. As seen in Figure 4 (right hand lanes), the pattern of hybridization 
from infected nuclei is different from the hybridization pattern from infected 
cytoplasm. Almost the entire genome, except clone B, is transcriptionally active 
Figure 4: Hybridization of cytoplasmic and nuclear lE-RNA to cloned (137) BHV-1 (Cooper) Hin^m 
fragments. Left lanes, restriction fragments (see Table 2 for fragment sizes). Center lanes, 
Southan blots probed with cytoplasmic lE-RNA. Right lanes. Southern blots probed with 
nudear SNA. Bar, pBR322. » fragments testing positive for hybridization to Œ-KNA. CT, 
calf thymus DNA. The results are summarized in Rgure 5 
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Table 2. Restriction endonuclease digests and expected fragments used in 
Figure 4 
clone J M I E G A B L D O K Bovine 
DNA 
digest H» H H H H Kb H H PC Rà P H 
Be R B R B sf 
R 
fragments 9.0» 4.4 8.2 8.8 8.0 lis 8.6 7.7 5.6» 4.7»»'» 2.8 
(kilobase 4.4 3.7 4.0 4.7 4.0 7.0 7.6 4.4 4.3» 2.1» 
pairs) 3.5 4.4 3.9 5.9 4.0 3.7# 1.35» 
0.3 0.3 1.9 2.9 2.0k» 0.94» 
0.3 1.6» 0.9» 
0.9 0.84» 
0.6» <0.8 
«Hindin. 
bKpnl. 
«TSg. 
dEcoRl. 
cBamHl. 
fgall. 
86.6 kb of fragment A + pBR. 
hO.4 kb of fragment O + pBR. 
'0.1 kb of fragment D + 3.6 kb of pBR. 
jl.2 kb of fragment D + 0.8 kb of pBR. 
outlineVector, pBR322, alone. 
^Fragments testing positive for hybridization to lE-RNA. 
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Figure 5: BHV-1 (Cooper strain) DNA. (A) The BHV-1 genome consists of a long unique sequence (L) and a short 
sequence (S). The short sequoice consists of a short unique sequence (thin line) flanked repeated se­
quences (IR-intemal repeat, TR-tenmnalrq>eat). (B) Restriction endonudease map for HindHl. (C) Re­
gions of the genome showing strong intensity (+) of and negative (-) hybridization to lE-RNA. Frag­
ments N and F were not cloned so Aey were not tested (o) 
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in BHV-1 infected-CHX treated MDBK cells. Clones A, E, G, I, L, and M show the 
strongest intensity of hybridization to nuclear RNA. The faint intensity of 
hybridization that these clones show for cytoplasmic RNA may be due to the 
nuclei leaking these RNAs into the cytoplasm during separation of cytoplasmic 
and nuclear fractions. Clones D, K, O, and pDK-1 show faint to weak intensities 
of hybridization to nuclear RNA and strong intensities of hybridization to 
cytoplasmic RNA. The clones that show the strongest intensities of hybridi­
zation to cytoplasmic RNA are considered to contain IE genes. A similar 
partitioning of nuclear RNA versus cytoplasmic lE-RNA has been reported for 
HSV-1 infected-CHX treated cells (114). The mechanism for this phenomenon 
has not been elucidated. One possible explanation for this partitioning of 
cytoplasmic and nuclear transcripts is the observation that CHX induces 
transcription from some promoters. The nuclear transcripts might be from CHX 
inducible BHV-1 promoters and these transcripts may not be transported to the 
cytoplasm. This has not been investigated. No hybridization was detected when 
probing the BHV-1 genome with uninfected cellular cytoplasmic or nuclear 
RNA nor was there any hybridization detected between total genomic bovine 
DNA and BHV-1 infected cellular RNA, cytoplasmic or nuclear (Figure 4). 
Likewise, no hybridization was detected between BHV-1 infected and uninfected 
cellular RNA and phage lambda and pBR322. Hybridization to clones D, ], K, and 
O are BHV-1 specific and these clones are considered to contain IE genes 
(summarized in Figure 5). 
Mapping of Fragments D, K, O, J and M 
To further localize these regions of hybridization, restriction endonuclease 
maps were constructed for D (Figure 7), K and O (Figure 9), and J (Figure 11), and 
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Southern blots were probed with lE-RNA, as previously described; for D (Figure 
6), K and O (Figure 8% and J (Figure 10). The size of each restriction fragment of 
each clone was carefully determined by comparison with HindlH/EcoRl diges­
tion fragments of phage lambda DNA. In instances where the restriction frag­
ments of the done were larger than 5.24 kb, Hindm digestion fragments of phage 
lambda DNA were used for comparison. Whenever the size of restriction frag­
ments of the clone was determined, appropriate digestions of phage lambda were 
used to generate fragments that would bracket the fragment of unknown size. 
Restriction fragments of the clone less than 0.58 kb were determined by using 
Haein digests of pBR322. Cleavage maps of each clone or subclone were then 
prepared by measuring the fragment sizes resulting from single and double di­
gests with unambiguously known restriction sites. Restriction endonuclease 
sites for EcoRl. BamHI. and Hpal have been reported by Mayfield et al. (137). 
Some restriction sites that appear very close to other known restriction sites have 
been reported as 0.1 kb apart. 
Mapping of fragment D 
Figure 7 shows the restriction endonuclease map of Hindm fragment D for 
FMI/ Sail, and KpnI. There are three Xhol sites in fragment D, only one is shown, 
in pHDP4.3. A complete Xhol map can be found in reference 196. There are two 
Hincn sites, one coincident with the unique Sail and the other within the PstI 1.6 
kb fragment 0.3 kb from pHDP4.3. There are at least 16 Smal fragments, adding 
up these fragments results in 0.6 kb of D being unaccounted for. One Smal site is 
0.8 kb from fragment O in pDK-1 and another is 1.2 kb away from fragment L in 
pHDF6.5. There are three Smal fragments of approximately 1.8 kb. One spans 
Table 3. Restriction endonudease digests and expected fragments for Hindin fragment D and 
subdones pHDP6.5, pHDP4.3, and pDK-1 
done D pHDP6.5a dHDP43 pDK-1 
restriction digest Pb HfC Md R/X/pe Sm/pf Sm/Rg P/Hh 
fragments 5.6» 3.3»/* 2.1)'» 3.6 4.4 4.0k 3.6 
(kilobase 4.3* 1.8- 1.8- 3.4» 1.8» 1.8l» 1.6» 
pairs) 3.7ni 1.2» 1.4 0.8 1.4* 1.1 1.2» 
2.0O,* 1.0 0.9» 0.5» 1.1» I IP 
1.6» 0.6» o.7q 0.4*" 
0.9 0.5s 0.6» 
0.6» ^0.4 <0.6 
^Contains PstI 5.6 and 0.9 kb fragments of D. 
CHinfl. there are 10 sites in pBR322. 
^MboII. there are 11 sites in pBR322. 
eEooRl/XhoI/Pstl. 
fSmal/Pstl. 
gSmal/EcoRl. 
hpsa/Hindm. 
ilO kb of pHDP6.5 +1.3 kb of pBR. 
jl.7 kb of pHDP6.5 + 0.4 kb of pBR. 
kO.4 kb of pHDP4.3 + 3.6 kb of pBR. 
^Doublet, fragmoit of 1.8 kb and 1.1 kb of pHDP4.3 + 0.8 kb of pBR. 
n*0.1 kb of D + 3.6 kb of pBR. 
'KZontains EcoRl site. 
01.2 kb of pDK-1 + 0.8 kb of pBR 
P0.4 kb of pDK-1 + 0.8 kb of pBR, 0.4 kb of pDK-1 is shared by pHDP4.3. 
^Triplet. 
'Pstt/EcoRl fragment shared by pDK-1. 
^Doublet. 
^Fragments testing positive for hybridization to lE-RNA. 
outlineVector, pBR322, alone. 
~Weak intensity of hybridization. 
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the unique EcoRl site and is adjacent to the Smal 1.8 kb fragment located in 
pHDP4.3. The third 1.8 kb fragment spans the unique Kpnl site. The other Smal 
fragments cannot be unambiguously located. 
Subclone pHDP6.5 consists of Pgg fragments 5.6 and 0.9 kb. The unique 
Ball site in pHDP6.5 was mapped using pHDP6.5. It is not known if any Ball sites 
are located in the other regions of D. 
The boundaries of the repeated sequence flanking the short unique seg­
ment have not been precisely mapped. The EcoRl site in fragment D is con­
tained in the repeated sequence (137), but it is known how far toward fragments 
O and K it extends. One can estimate the location of this boundary from the 
Hindm map to be from 0.3 to 0.5 kb into pDK-1 from fragment O or 
approximately 2.9 to 2.7 kb from the unique EcoRl site in fragment D. The 
opposite end of the repeat located at the junction with the long unique segment 
lies somewhere between the unique Sail and Kpnl sites. 
Mapping of fragments K and O 
Figure 9 shows the restriction endonuclease map of Hindm fragments K 
and O for Sail, £sjtl, Xhol. and BstEU. No Kpnl sites were identified. During 
construction of the Hindm clone collection fragment O was cloned both 
independently and together with fragment K. Generally, plasmid pSD98 which 
contains both fragments in the same order which they occur in the viral genome 
was used for analysis. 
Mapping of fragments T 
Figure 11 shows the restriction endonuclease map of Hindm fragment J 
for Xhol. £sil/ and.^âU> A unique Kpnl site is located 1.7 kb from the Hindm site 
separating fragments J and N. There are at least Ave Xhol sites, two of which can 
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Table 4. Restriction endonudease digests and expected fragments for Hindm 
fragments K and O used for Figure 8 
restriction Sail Sail/ m BstEH/ 
digest EStf 
fragments 4.8* 4.8» 5.9* 5.9b,» 
(kilobase 2.15* 2.15* 3.7c,» 3.8» 
pairs) 1.7d'* 1.7d'» 1.6» 3.7c 
1.35e»» 1.35» 0.8 1.6» 
0.84 0.84 0.4 0.8 
0.64 0.64 0.25 0.4 
0.58f,» 0.25g 
0.5%» 
0.3f,h 
^1.0 kb of fragment K + 3.6 kb of pBR. 
^Partial digest of PstI 5.9 kb fragment by BstEII. 
<^0.1 kb of fragment K + 3.6 kb of pBR. 
^0.7 kb of fragment K + 0.4 kb of fragment O + 0.6 kb of pBR. 
^Doublet, both positive for hybridization to lE-RNA. 
'One Sali 1.35 kb fragment is cut by Xhol twice yielding three fragments. 
SThe placement of this fragment is not known. 
% is not known if this fragment is positive for hybridization to lE-RNA. 
outiineVector, pBR322, alone. 
^Fragments testing positive for hybridization to lE-RNA. 
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Table 5. Restriction endonudease digests and expected fragments for Hindm 
fragments J and M used in Figure 9 
clone T 
restriction 2asfiPEsfl Sail Es9 
digest 
fragments 8.6b,* 7.7C,» 6.6à,* 3.8* 
(kilobase 1.4» 1.7* 4.2 2.5 
pairs) l.Of 1.3» 2.3 16-
0.4 1.2g 0.3h 0.4 
0.8 
0.6 
^Fragment J is 13.4 kb, 1.0 kb can not be accounted for. 
^Contains 4.4 kb of pBR. 
C4.1 kb of fragment J + 3.6 kb of pBR. 
<*2.8 kb of fragment J + 3.8 kb of pBR. 
^0.2 kb of fragment M + 3.6 kb of pBR. 
^1.7 kb of fragment M + 0.8 kb of pBR. 
SDoublet. 
hO.4 kb of J -I- 0.8 kb of pBR. 
'The location of this fragment is not known. 
"^Fragments testing positive for hybridization to lE-RNA. 
"Weak hybridization to lE-RNA, presumed to be another dass. 
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be unambiguously located. Totalling the Xhol fragments leaves 1.0 kb of J 
unaccounted for. The intensity of the 1.0 kb doublet (Figure 10) is not enough to 
warrant calling it a triplet. 
Mapping of fragment M 
Figure 12 shows the restriction endonuclease map of Hindin fragment M 
for PstI. EcoRl. and Xhol. A unique Xhol site is located within the PstI 1.6 kb 
fragment 0.4 kb from the Hindm site separating fragments M and I. No Sail or 
Kpnl sites were identified. 
Mapping of IE Transcripts within Fragments D, K, O, J, and M 
Fragment D is 14.8 kb in length and nearly the entire fragment showed 
hybridization to IE RNA. PstI digests show hybridization to fragments of 5.6,4.3, 
1.6, and 0.6 kb. Two fragments were negative: 3.7 kb (contains pBR322 and 0.1 kb 
of D) and 0.9 kb . The results are seen in Figure 6 and Table 3 and are summar- -
ized in Figure 7. To finely map these positive regions of hybridization, the PstI 
fragments were cloned into pBR322. pDK-1 was previously constructed (218a). 
pHDP4.3 and pHDP6.5 were used for further study: Fragment D contains one 
possible IE gene beginning 1.0 kb into pHDP4.3 from pDK-1 (there is no hybrid­
ization detected where pHDP4.3 and pDK-1 overlap) through pHDPO.6 (0.6 kb) 
and 2.4 kb into pHDP6.5. Hinfl and MboII fragments of 1.8 kb show faint inten­
sities of hybridization and may contain a small portion of the gene. Thus, frag­
ment D contains a continuous 5.9 kb region of hybridization to lE-RNA approx­
imately located within the repeated sequence flanking the short unique segment. 
It is not known if the other repeat flanking the short unique segment, Hindlll 
fragment F, also tests positive for hybridization to lE-RNA. There do not appear 
to be any introns in this region, though no experiments have been done to 
Figure 6: Hybridization of cytoplasmic lE-KNA to restriction fragments of HindPI fragment D and three 
subclones of fragment D. (D). PstI (P) digest of fragment D. (pDHP6.5). Hinfl (Hf) and MboII 
(M) digests of pHDF6.5. (pHDP4.3), EcoRl (R)/XhoI (X)/Pstl (P), Smal (Sm)/Pstl (P) and 
SmaI(Sm)/PstI (P) of pHDP4.3. (pDK-1), (P)/Hindin (H) digest Of pDK-1. Left lanes, 
restriction digests (see Table 3 for a list of fragment sizes). Right lanes. Southern blots 
showing fragments testing positive for hybridization to lE-RNA. The results are summarized 
in Figure 7 
pHDP6.5 
P Hf M 
PHDP4.3 pDK-1 
R/X/P Sm/P Sm/R P/H 
7: Hybridization summary of lE-RNA to Hindm fragment D. (A) Restriction endonudease map for 
Hindm (H) fragment D for Pstf (P), Sg[ (S), W (Ba), Kgd (K), EcoRl (R), and 20^1 (X). Hindm 
fragments L and O are located to the left and to die right, respectively, ctf fragment D. (B) Restriction 
endonudease maps for subdones pHDP6.5, pHDP4.3, and pDK-1 of fragment D forHinflE (Hf), Mboll 
(M), Pstl^d Smal (Sm). (C) PstI fragments of fragment D testing positive (+) or negative (-) for 
hybridization to lE-RNA. (D) Restriction fragmaits of pHDP65, pHDP43/ and pDK-1 revealing 
regions with strong (+), weak (~), and negative (-) intensities of hybridization to lE-RNA. (E) Two 
regions, 5.9 and 3.2 kb, within D are positive for hybridization to lE-RNA 
A Hindni Fragment D ^ g 
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directly address this question. 
Another IE gene may be found in fragment D. pDK-1 contains a 2.8 kb 
fragment that is positive for hybridization to lE-RNA and is located partially 
within the short unique segment and the repeat flanking the short unique seg­
ment. It is 1.0 kb away from the 5.9 kb region of hybridization discussed above 
though it may or may not be distinct. Next to pDK-1 is fragment O (0.4 kb) which 
is positive for IE RNA. It is possible that fragment O and pDK-1 contain an IE 
gene of 3.2 kb. 
Fragments K and O are 8.4 kb in length. There are three distinct regions of 
hybridization to lE-RNA. The results are seen in Table 4 and Figure 8 and are 
summarized in Figure 9. One major region is 3.0 kb located from the S^I site to 
the left (toward fragment D) of the unique BstElI site and within the entire Sail 
1.35 kb fragment containing two Xhol sites. It is not known if the Xhol 0.3 kb 
fragment is positive for hybridization to lE-RNA, but it is presumed to be for this 
analysis. There is a weaker region of hybridization within the other Sail 1.35 kb 
fragment and the PstI 1.6 kb fragment. The faint intensity of hybridization may 
be caused by low level franscription of another class or a very short abundant lE-
RNA. Quantitative studies have not been done to determine which is the case. 
The third region of hybridization to lE-RNA contains fragment O, Sail 1.7 and 
PstI 3.7 kb fragments. The Sail 1.7 kb fragment shows strong intensity of 
hybridization to lE-RNA while the PstI 3.7 kb fragment does not. 3.6 kb of this 
fragment is pBR322. The difference in intensities probably results from a more 
stable hybrid forming between the longer target sequence within Sail 1.7 kb 
fragment and lE-RNA. The length of this sequence is not known. The PstI 0.4 kb 
fragment is located within this region and tested negative for hybridization to IE-
Figure 8: Hybridization oi cytoplasmic lE-RNA to rândm fragments K and O. Left lanes, restriction 
fragments for SaU (S), SaU (S)/XhoI (X), M (P), and BsŒH (Bs)/M (P) (see Table 4 for 
fragment sizes). Right lanes, Southern blot showing fragments hybridizing to lE-KNA. p, 
pBR322. Solid squares, fragments testing positive for hybridization to IE-RNÂ. Tapered 
arrows, S^ 1.35 kb fragments when digested witii XhoL Double solid squares, S^ 1.35 kb 
fragment showing moderate hybridization to lE-RNA. n, 5.9 kb fragment cut by BstEII 
testing negative for hybridization to lE-RNA. The results are summarized in Figure 9 
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Figure 9: Hybridization summary of lE-RNA to Hindlll fragments K and O. (A) Restriction endonudease map of 
Hm^UH (H) fragments and K for PstI (P), Sail (S), Xhol (X), and BstElI (Bs). No sites were found for KpnI. 
Hm^ fragment D is located to the left of fragment O and Hindlll fragment F is located to the right of 
fragment K. (B) (C) Sail, and (D) Sall/Xhol restriction fragments of fragments K and O revealing 
strong intensity (+) of and negative (-) hybridization to lE-RNA, (o) fragment too short to be detected. 
(E) Three regions, 0.4,1.35, and 3.2 kb, within fragments K and O showing strong intensities of 
hybridization to lE-^A 
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RNA. The negative result may be explained by this A"agment being too short to 
efficiently bind to the transfer membrane. Fragment O which is about the same 
size tested variably positive for hybridization to lE-RNA (Figure 4). For this 
analysis we do not consider the 0.4 kb PstI A-agment to be positive for hybridiza­
tion to lE-RNA. We consider this region of hybridization to be continuous with 
the region of hybridization in pDK-1, forming a 3.2 kb region of hybridization. 
In the Sail and Sall/Xhol digest experiments, bands not considered to test 
positive for lE-RNA show faint intensity of hybridization. There are at least 
three possible explanations. One possibility is the major transcript coded for by 
this region is processed. The ICPO mKNA of HGV-1 is processed and contains 
two introns (180a). lE-RNA used in this study was purified from infected cell 
cytoplasm and should not contain excised introns. A second possibility is low 
level transcription of other classes. Glycoprotein gIV is coded for by this region 
and is expressed as DE (125,167). A third possibility is nonspecific hybridization 
caused by less than stringent conditions as used for the other hybridization 
studies. Experiments have not been done to differentiate from among these 
possibilities. 
Hindm fragment J is 9.0 kb in length. There are two major regions of 
hybridization to lE-RNA: 2.6 kb fragment next to Hindm fragment M and a 1.7 
kb fragment next to Hindm fragment N. The results are seen in Table 5 and 
Figure 10 and are summarized in Figure 11. The 2.6 kb region of hybridization 
does not appear to continue into fragment M (see below). We do not know if N 
is positive for lE-RNA, as N was not cloned when the BHV-1 clone collection 
was constructed. This could be tested if genomic DNA extracted from mature 
virions were to be probed with lE-RNA. This experiment was attempted, but 
10: Hybridization of cytoplasmic lE-RNA to Hindlll fragments J and M. Q), left lanes, restriction 
endonudease fragments for Xhol (X), (P), and Sail (S) (see Table 5 for fragment sizes); 
right lanes. Southern blots showing restriction fragments testing positive for lE-RNA. (M), 
left lane, PstI (?) fragments (see Table 5 for fragment sizes); right lane. Southern blot showing 
weak hybridization to lE-RNA. The results are summarized in Hgures 11 0) and 12 (M) 
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C  E s t f  + + + + + + + + + + + + + + + + + + + + + + + + + + + I  I  - I + + + + + + + + + + + I + + + + + + + + + I .  
D Summary I+ + + + + + + + + + + I- I +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  1  1  
Hgurell: Hybridization summary of lE-RNA to Hindlll fragment I. (A) Restriction endonudease map of Hindlll (H) 
fragment J for gaU (S), ^ 1 (P), Hpal (Hp), Kpnl (K), and Xhol (X). There are at least fiye Xhol sites, but only 
two of titese could be placed unambiguously. Hindlll fragments N and M are located to the left and to the 
right, respectively, of J. (B)§aU and (C)]^ fragments of J revealing regions with strong intensity of (+) and 
negative (-) hybridization to lE-RNA. (D) Two regions, 1.7 and 26 kb, within J positive for hybridization to 
lE-RNA 
A Badin Fiagment M h R X H 
' Yn  ^
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Figure 12: Hybridization summary of lE-RNA to Hindlll fragment M. (A) Restriction endonudease map of 
Hindlll (H) fragment M for Pstl (P). EcoRl (R).andXh(d. No sites were found for Sail and Kpnl. 
Hm^ll Pigments J and I are located to the left and to the right, respectivdy, of fragment M. (B) 
fragments of M revealing weak intensity (~) of and negative (-) hybridiâtion to lE-RNA 
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BHV-1 DNA of suitable quality was never obtained. We do not know if these 
two regions of hybridization are one gene separated by a large intron or two 
separated genes. Also complicating analysis of J is Uie fact that the restriction 
map is poorly determined. 
Hindm fragment M is 3.7 kb in length and is not thought to contain an IE 
gene. The 2.6 kb region of fragment J testing positive for lE-RNA was close to 
fragment M. PstI digests of fragment M were probed with lE-RNA to see if the 2.6 
kb region continued into fragment M. The results are seen in Table 5 and Figure 
10 and summarized in Figure 12. There was no detectable hybridization of lE-
RNA to fragment M within Z9 kb of fragment J. A faint 1.6 kb region of 
hybridization was detected closer to Hindm fragment I and is presumed to be 
another class. 
We have identified from three to five possible IE genes by hybridizing IE-
RNA to Hindm fragments D, ], K, and O. Fragment D contains one region of hy­
bridization of 5.9 kb and another one of 3.2 that continues into fragment O. Frag­
ment K contains one region of hybridization of 3.0 kb away from fragment D and 
another region of weaker hybridization between fragment O and the 3.0 kb 
region of fragment K that may be another class. Fragment J contains two regions 
of hybridization of 2.6 kb near fragment M and 1.5 kb near fragment N; it is not 
known if this continues into fragment N. We have identified three possible IE 
polypeptides of 46,140, and 180 kD. Polypeptides of 180,140, and 46 kD would 
require a minimum of 4.9,3.9, and 1.3 kb, respectively, assuming no posttrans-
lational modification. It is possible that the coding sequences of the 180 kD 
polypeptide is contained in Hindm fragment D. Fragment D, subclones pHDP4.3 
and pHDP6.5, contain the inverted repeats that flank the short unique region. 
Figure 13: Fluorograph of in vitro translated poly A* lE-RNA hybridized to BHV-1 clones testing 
positive for hybridization to lE-RNA. The polypeptides were separated by SDS-PAGE on a 
10% gel. (A), C,unhybridizedIE-RNA; 4.3, pHDP4.3 hybridized to lE-RNA. (B),pHDP6.5 
(65), pBR322 (p), IfiQjyn fragments J 0) and K (K) hybridized to lE-RNA; C, unhybridized lE-
RNA controls. (C), IE, unhybridized Œ-RNA; U unhybridized uninfected œllular RNA 
extracted from cells treated with (+) or without (-) CHX. A, B, and C are three diAerent 
ecperiments. Poly A"*" lE-KNA used for A and B are from die same preparation 
c 4.3 6.5 p J K IE -U K 
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Other herpesviruses contain a high molecular weight IE polypeptide in this 
region: HSV-1 (175 kD), PRV (180 kD), and EHV-1 (180 kD). 
In vitro Translation and Hybrid Arrest 
To confirm which polypeptide is coded for by which region of the genome, 
we used the technique of hybrid arrested-in vitro translation (HA-IVT). Figure 
13C shows IVT of poly A+ RNA from 5 1/2 hr BHV-1 infected-CHX treated cells, 
uninfected cells, and uninfected-CHX treated cells separated by 10% SDS-PAGE 
and visualized by fluorography. The virally infected lane shows three unique 
bands not present in the other two lanes: 40,140, and 180 kD. Addition of CHX 
to uninfected cells does not induce or stabilize any poly A+ RNA that codes for 
polypeptides of these sizes. We conclude that these three polypeptides are BHV-1 
specific, IE and their mRNAs are polyadenylated. It appears that the 140 kD and 
180 kD polypeptides are minimally or not posttranslationally modified; the in 
vitro synthesized polypeptides have the same electrophoretic mobility as in vivo 
labeled products. 
In vitro translation of poly A+ RNA from 5 1/2 hr BHV-1 infected-CHX 
treated cellular RNA shows five viral polypeptides: 40,46,140,150, and 180 kD 
(Figure 13A lane c). IVT of BHV-1 poly A+ lE-RNA hybridized to both pHDP4.3 
and pHDP6.5 greatly reduces expression of the bands of 140 and 180 kD, and 
possibly of 40 and 46 kD. The bands of 40 and 46 kD are not obvious and are 
variable among experiments. The resolution on these short gels is poor, but the 
40 and 46 kD polypeptides can be detected on a longer gel (see below). M vitro 
translation of fragments J and K and pBR322 hybridized to poly A+ lE-RNA 
shows no altered expression of any BHV-1 polypeptides. We conclude that 
Kn^m fragment D, subclones pHDP4.3 and pHDP6.5, contains the gene for three 
Figure 14: Fluorograph of ^^s-methionine (met) and ^H-leucine (leu) 
labeled in vitro translated poly A+ RNA extracted from 
uninfected (U) and BHV-1 infected (IE) cells. The 
polypeptides were separated by SDS-PAGE on a 7.5-12.5% 
gradient gel. Large arrow, 46 kD polypeptide. Small arrow, 
diffuse band of 39/40 kD. The two IE lanes for each labelling 
are from two different RNA extractions 
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IE polypeptides of 180,140 and 46 kD. EHV-1 shows a similar, variable/multiple 
IE polypeptide. The major IE polypeptide in this virus is 180 kD with three other 
minor IE polypeptides of lower molecular weight translated from the same 
transcript (see discussion). 
Hybrid arrested-WT using J and K did not show reduction of any IE poly­
peptides, though resolution on these gels is very poor below 100 kD. Southern 
analysis showed these regions to be transcriptionally active. The polypeptides 
encoded by these clones may not contain 35S-methionine residues and would not 
have been detected by this experimental design. In vitro translation of poly A+ 
lE-RNA was labeled using ^H-leudne instead of ^^S-methionine, separated by 
10% SDS-PAGE, and visualized by fluorography (Figure 14) shows BHV-1 specific 
polypeptides of 180,150,140,46 kD, as seen with ^^methionine labeling, and 
three new ones of 35,37, and 39 kD (Figure 14). The three polypeptides of 35,37, 
and 39 kD can be seen in the 35s-methionine labeled lane as a faint diffuse area. 
These three polypeptides may be compressed as one band of 40 kD on the shorter 
gels used above. We do not know if fragments J and K code for these products or 
if these are proteolytic products from the 180 kD protein. There are two regions 
of hybridization in fragment J, one region of hybridization spanning fragment O 
and pDK-1, and one major and one minor region of hybridization in fragment K. 
Northern Analysis 
Hybrid arrested-IVT results suggest that three IE polypeptides of 140 and 
180, and possibly 46 kD are franslated from a transcript or transcripts homologous 
to the 5.9 kb region of hybridization in pHDP6.5 and pHDP4.3. There are four 
possibilities to explain how three polypeptides could be coded for by the same re­
gion of DNA. There could be three genes in the same region resulting in three 
Figure 15: Northern analysis of total uninfected cellular (Un) and total BHV-1 infected RNA extracted 
from infected cells at 1,2,3, and 4 hpi and from CHX-treated cells (IE). Hie blot was probed 
with nidc translated pHDP4.3. (M), single stranded molecular markers stained with 
ethidium bromide (kb) 
hp! 
UN IE 1 2 3 4 
• • W-A 
9.49 
7.46 
4.40 
2.37 
1.35 
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different transcripts, or one primary transcript that is alternately spliced to yield 
three mRNAs, or there could be one transcript containing three different start 
codons, or the primary polypeptide translated could undergo proteolytic cleavage 
after synthesis to yield two other polypeptides of lower molecular weight. To 
identify the number of transcripts coded for by pHDP4.3 we used the technique of 
Northern blotting. Fifty micrc^rams of total BHV-1 infected cellular RNA 
extracted at 1,3, and 4 hpi and Arom 51/2 h BHV-1 infected CHX-treated cells 
(IE), were denatured with glyoxal, separated by agarose gel electrophoresis, 
transferred to a blotting membrane, and probed with pHDP4.3 labeled with 32p_ 
dCTP by nick translation (Figure 15). In the IE lane one prominent band of 5.2 kb 
is seen. This band is fainter but present at 2,3, and 4 hpi. The band is absent 
from uninfected controls.. Thus, fragment D contains one primary transcript of 
5.2 kb that is superinduced in the presence of CHX and is either transcribed at a 
low level throughout the infectious cycle or it has a long half-life. Work with 
HSV-1 shows that IE transcripts are present at low levels throughout its 
infectious cyde (83). 
In summary, a 5.2 kb transcript codes for the 140 and 180 kD, and possibly 
the 46 kD, polypeptides. It is not known if there are different open reading 
frames, yielding three polypeptides from the same mRNA, or if there is one 
primary translation product of 180 kD that is somehow processed to two products 
of 140 and 46 kD. Sequencing this region would differentiate between these two 
possibilities. Probing with HindM fragments J, K, and O and pDK-1 has not been 
successful. 
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DISCUSSION 
We have identified six regions of hybridization to lE-RNA. One of these 
we have shown to be an IE gene. The others are not well characterized and the 
class to which they belong is ambiguous. These regions are located in Hindlll 
fragments D (one region of 5.9 kb [which contains the IE gene] and one of 3.2 kb 
that includes fragment O), K (two regions of 3.0 and 1.35 kb), and J (one region of 
2.7 kb and one of 1.5 kb that might continue into fragment N). We have 
identified three IE polypeptides of 180,140, and possibly 46, kD; there may be 
three more of 39,37, and 35 kD. These later three were not seen in Figure 4, lane 
4b, but resolution was poor in this region of the gel and these polypeptides are 
not labeled extensively with 35s-met (Figure 14). To establish whether or not 
these later three are IE polypeptides, we would need to repeat the experiment 
shown in Figure 4, but with ^H-leu label. This way, the background of host 
polypeptides would be reduced and, if synthesized as IE, these three polypeptides 
should be detected. It is possible that these three polypeptides may be an artifact 
of IVT caused by premature termination of translation, or be different disulfide 
reduction states of the 46 kD polypeptide, or be degradation products. In Figure 
13C the 40 kD band is very intense but no 46 kD band is seen. On other gels when 
the 46 kD band is seen the 40 kD band is diffuse or absent, suggesting that the 46 
kD band may be the fully denatured-reduced form and the 35,37,39 kD bands are 
less reduced forms. In Figure 14 these bands are not distinct but diffuse into one 
another, though the 37 kD band is the most intense of the diree. A diffuse band 
on an SDS-PAGE may also be caused by glycosylation, but the bands on Figure 14 
are IVT products and, therefore, not glycosylated. To test the speculation that the 
four are related, we need to repeat the IVT labelling with ^H-leu and separate the 
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polypeptides on a long gel, using pHDP6.5 and pHDP4.3 (our data suggests the 46 
kD is related to 180 and 140 kD polypeptides) hybridized to lE-RNA. If they are 
related/ synthesis of all these polypeptides would be blocked. These three might 
also be encoded by the other potential IE genes located in fragments J, K, and 
pDK-1. Wirthgtal. have identified three IE polypeptides of BHV-1 of 180,135, 
and 50 kD that are all labelled with 35S-met or 32p.p04 (271). Misra etal. reported 
four IE polypeptides of 182,166,93, and 91 kD (153). The 182/166 kD pair probably 
corresponds to the 170/180 pair we identified in Figures 3 and 4, but the 140 and 
46 kD polypeptides were not identified, unless the 180 kD polypeptide is 
processed into Ae 91/93 kD pair reported by Misra gt al. Metzler identified one 
major IE polypeptide of 180 kD and six minor ones of 170,135,98,94,46, and 35 
kD (dted in 270). These roughly correspond to the ones we have identified 
except for the 98 and 94 kD polypeptides. One can speculate that different strains 
and host cells could have factors that process the protein differently or initiate 
translation at different regions of the IE180. This would result in the 180 kD 
polypeptide being processed into products of 91 and 93 kD (152), or into 46 and 
140 kD (this communication), or 50 and 135 kD (270), or 135,98,94, and 46 kD 
products (dted in 270). The high molecular weight companion of IE180 may be 
an altered phosphorylation state (180a). 
Northern analysis of lE-RNA shows one transcript of 5.2 kb identified by 
pHDP4.3. This together with hybrid arrest data suggests that the three IE polypep­
tides of 180,140 and 46 kD are translated from the same mRNA, though three 
different mRNAs of the same length can't be ruled out, or that there are three 
different ORF on the one 5.2 kb mRNA that encodes each of these. It is also 
possible that the 180 kD polypeptide is processed into the 140 and 46 kD products. 
7 5  
If so, this occurs both in vivo and in vitro. One would not expect a regulatory 
process present in infected cells to be present in an IVT system, though 
autocatalysis cannot be ruled out. An analogous situation has been reported for 
EHV-1. EHY-1 is a member of the genus Varicellovirus (28), four IE polypeptides 
of 203,176,151, and 129 kD have been identified (32), are related (33), and are 
translated from a 6.0 kb mRNA (192) that maps to the inverted repeats of the 
short unique region (76,77). This IE gene has been sequenced revealing 38 ORFs 
greater than 300 base pairs in length, 11 ORFs potentially coding for polypeptides 
of greater than 100 amino adds, with the longest ORF coding for a polypeptide of 
155 kp (80). The amino add composition of the predicted IE155 polypeptide is 
such that the electrophoretic mobility in SDS-PAGE is predicted to be approx­
imately 205 kD, which is the observed size of the largest of the four EHV-1 IE 
polypeptides (80). Northern, SI, and primer extension studies reveal that the IE 
mRNA from this gene contains no major introns in the body of the transcript, 
but there is a 378-base intron at the 5' end in the leader sequence (84). These data 
suggest alternate initiation codon usage results in four polypeptides from the 
same mRNA. One could speculate that a similar phenomenon is exhibited by 
BHV-1, but the experiments to determine the relationship between the 5.2 kb IE 
mRNA and the three IE polypeptides have not been done. Sequence analysis of 
the BHV-1 inverted repeat has been undertaken (214). Wirth et al. report two 
major lE-RNAs of 4.2 and 2.9 kb. The former is located within the repeated 
sequence and is homologous to HSV-1ICP4 (ICP4) and SHV-1 (IE180) sequences, 
and the latter is located at the junction of the repeated sequence and the long 
unique segment (270). It seems that there are strain differences in the size of the 
lE-RNA encoded by the repeated sequence. We did not detect any lE-RNA from 
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the long unique, repeated sequence junction. The 2.9 kb RNA reported by Wirth 
e&al. (270) may be the LAT that is transcribed at IE times in some BHV-1 
strain/host cell combinations, but may not be in others. It is possible that this 
lE/LAT may have been transcribed in our system at a level below our detection 
limits. 
Our results indicate that the BHV-1 180 kD gene is located within the 
repeated sequence flanking the short unique segment. While the exact boundary 
of this repeated sequence is not known, one can estimate the location of the 
junction to be 0.3 to 0.5 kb into fragment D from Hindm fragment O (see Figure 2 
and 137). The 3.2 kb region contained in clone pDK-1 is thus partitioned, rough­
ly, 2.3-2.5 kb in the repeated sequence and 0.7-0.9 kb in the unique short segment. 
The region is positive for hybridization to lE-RNA which does not code for a 
known IE polypeptide but further characterization has not been done. Wirth et 
al. report a major 1.6 (Jura) and 1.8 (K-22) kb lE-RNA for these regions of the 
genome. We have not determined the size of the lE-RNA from this region for 
the Cooper strain. The junction between the short repetitive and short unique 
regions of HSV-1 contain two IE mRNAs. Both contain the same 260-base 5' end, 
contain an intron of approximately 150 bp (derived from the repeated sequence), 
and are approximately 1.5 kb in length (260b). These mRNAs code for 
polypeptides of 12 (ICP47) and 68 (ICP22) kD from a transcript of 1.8 kb (254). 
Some other Varicelloviruses do not have an lE-RNA that spans the repeated 
sequence and the unique segment, making the IE transcription pattern for this 
region of BHV-1 appear more like HSV-1. ICP22 does not cross-hybridize to 
BHV-1 (271). It will be interesting to see what the transcripts located at the 
repeated sequence, short unique segment boundary are translated into. 
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Fragment K contains two regions of hybridization to lE-RNA. Hybridiza­
tion to the Sail 1.35 kb fragment was less intense than other regions and may not 
be an IE gene. Glycoprotein gIV is transcribed as DE (125,167) and is approxi­
mately located in this region of the genome (270). The gIV gene is approximately 
1.3 kb in length (108a), so it could be located in this region. The other region of 
fragment K thought to contain a potential IE gene has not been further charac­
terized. Wirth St al. reported a number of DE and L transcripts located in this 
region, but did not report any lE-RNAs (270). It is possible that some DE genes 
have leaky promoters that can be transcribed to high levels during 51/2 hours in 
CHX. 
Fragment J also contains two regions of hybridization to lE-RNA. These 
regions have not been further characterized. 
In vitro translation of lE-RNA in our hands has variably identified a 150 
kD polypeptide. This is presumed to reflect the quantity of 150 kD mRNA 
present and not on some variable factor present in the IVT system or extraction 
procedure. Other groups have reported a virion component of 145 to 150 kD (34, 
153,179,215,223). Other herpesviruses contain a major capsid polypeptide 
between 148 and 155 kD (47) and the mRNA for this product is classifed as DE-L, 
leaky-late, or beta/gamma. This leaky-late class is easily identified at early times 
in the infectious cyde but becomes more abundant after DNA replication (254). 
Figure 3 shows a 150 kD polypeptide that is being synthesized at low levels at 2 
hpi, but which is increasingly synthesized until about 6-8 hpi. Synthesis levels 
off after 10 hpi, but still remains high. One dimensional gels, of course, cannot 
prove that there is only one virus encoded protein of 150 kD. A 150 kD polypep­
tide encoding mRNA is present in variable amounts in our lE-RNA prépara-
7 8  
tions. We interpret this variability to result from variability in the progression 
of the infectious cyde A^om experiment to experiment, probably due to slight 
differences in the health of the cells and viruses and completeness of CHX block. 
We speculate that this 150 kD polypeptide is the major capsid protein of BHV-1. 
Assuming that some leaky-late promoters are transcribed at low levels 
during the IE stage of the infectious cyde, we speculate that in the presence of 
CHX for 51/2 hours some leaky late transcripts accumulate to levels sufficient to 
give a positive hybridization signal as IE in our Southern analysis. Taking this 
speculation one step further, the gene for the 150 kD polypeptide might be 
identified by our collection of IE transcripts. An unprocessed polypeptide of this 
size would require a minimum of 4.1 kb assuming no introns. No regions of 
this size, except the one encoding the 180 kD protein have been identified. Hy­
brid selected-in vitro translation studies of poly A+ mRNA extracted from 18 
hour BHV-1, Canadian IBR strain #34, infected ovine kidney cells revealed a 150 
kD polypeptide coded for by the region between HindM fragments A and B (222). 
This polypeptide also reacted with antisera raised against purified BHV-1 virions, 
and so, is a candidate for a virion component (222). It is not known if this is the 
same 150 kD polypeptide that we report on. If it is, we still do not know what, if 
any, polypeptides are encoded by the other possible IE genes we have identified. 
It is possible that the intense regions of hybridization to lE-RNA in h-agments J, 
K, and pDK-1 are other than IE and are under translational control so they would 
be transcribed in the presence of CHX, accumulating to levels detectable by 
Southern blotting. However, one would expect such mRNAs to be translated 
during IVT. The polypeptide pattern of IE polypeptides synthesized in vivo is 
similar to the pattern of IE polypeptides synthesized in vitro in our experiments. 
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This study was undertaken to identify the IE products of BHV-1 to 
eventually understand the relationship, if any, between IE products and latency. 
It was hypothesized that the antisense arrangement of LAT and ICPO of HSV-1 
could form a duplex during infection of the neuron, turning off productive 
infection of the neuron and, thus, direct the virus into quiescence, the latent 
state. Recent work has shown the LAT is not required for establishment or 
maintenance of latency in HSV-1. ICPO mKNA is not transcribed during latency, 
suggesting some other factor(s) was directing the virus into latency. There does 
not appear to be a relationship between establishment and maintenance of 
latency and IE products. Similarly, we have shown that for BHV-1 (Cooper) 
grown in MDBK cells the IE genes are distinct from the region encoding the LAT. 
This contrasts with the results of others. For BHV-1 (Cooper) grown on bovine 
lung cells (165) and BHV-1 (Jura and K-22) grown on MDBK cells (270) there is an 
IE transcript encoded by the same region of the genome as the LAT. This is 
difficult to explain. Although the striking differences between nuclear and 
cytoplasmic RNAs found in this study need to be followed up more extensively. 
While the case for IE and LAT being involved in establishment and 
maintenance of latency is weak, some important questions remain. What are 
the signals that potentiate and turn off a productive infection of a neuron to 
establish latency and initiate synthesis of LAT? What are the mechanisms that 
initiated reexpression h'om latency? This can be thought of as a two step process. 
How do environmental factors signal the end to maintenance of latency and 
how does end of maintenance of latency signal initiation of a productive 
infection of the neuron beginning reexpression of a lytic infection of the neuron 
and producing new virus particles? Dexamethasone induced reexpression of the 
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latent BHV-1 virus makes this an attractive model system to further investigate 
the mechanisms of reexpression of an alphaherpesvirus from latency, to achieve 
this goal, a better understanding of the role of IE products is essentia. 
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